Editors: Siegel, Marilyn J.
Title: Pediatric Body CT, 2nd Edition
> Table of Contents > Chapter 10 - Adrenal Glands, Pancreas, and Other Retroperitoneal Structures
Chapter 10
Adrenal Glands, Pancreas, and Other Retroperitoneal Structures
Paul Babyn
Marilyn J. Siegel
Computed tomography (CT), especially with multidetector technology, has become an important diagnostic imaging examination for evaluation of known or suspected retroperitoneal disease (1,2). With modern CT scanners and optimized CT scanning techniques, normal and abnormal retroperitoneal anatomy and pathologic conditions can be recognized even in small children with little retroperitoneal fat.
The retroperitoneum is bordered superiorly by the diaphragm, inferiorly by the pelvic brim, anteriorly by the parietal peritoneum, and posteriorly by the transversalis fascia (3). Located within this compartment are the adrenal glands, pancreas, kidneys and ureters, duodenal loop and ascending and descending colon and great vessels and their branches, as well as smaller structures including lymph nodes, lymphatic channels, and nerves. This chapter reviews the normal anatomy and common pathologic disorders of the adrenal glands, pancreas, lymph nodes, and retroperitoneal soft tissues. The psoas muscles and adjacent sympathetic trunks, which actually lie posterior to the retroperitoneum within the retrofascial space, are also included because conditions affecting these structures can involve the retroperitoneal compartment. Diseases of the kidney, duodenum, and colon have been covered elsewhere in this book (see Chapters 8 and 9).
General CT techniques
Oral and Intravenous Contrast Agents
Oral contrast medium is routinely given to delineate bowel loops and to avoid mistaking bowel for an adrenal mass. Contrast agent is given 45 to 60 minutes before the CT examination and again 10 to 15 minutes before the start of scanning (1,2). (See Chapter 1 for more detailed information.) Water may be useful as an oral contrast agent when CT angiography is anticipated.
To improve delineation of abdominal and pelvic organs and identification of pathology, retroperitoneal CT studies are routinely performed with intravenous contrast medium, 2 mL/kg, not to exceed 125 mL. Flow rates vary with angiocatheter size; typical flow rates are: 1.5 to 2.5 mL per second for a 22-gauge catheter and 3 to 4 mL per second for a 20-gauge catheter.
Technical Factors
Similar to other parts of the body, the choice of slice collimation and pitch will vary with detector technology and the size of the structure of interest. For a 16-row detector, 0.75- to 1.5-mm collimation with a pitch of 1 to 1.5 suffices. For a 64-row detector, 0.6- to 1.25-mm collimation and a pitch of 1 to 1.5 suffice. Because most retroperitoneal masses are large in children, a thicker collimation (>1 mm) usually suffices. Thinner collimation (<1 mm) is used to improve visualization of small lesions and for CT angiography. A 5-mm section thickness at 5-mm intervals is usually adequate for routine viewing of the volumetric data, with thinner sections reconstructed as needed. Thin reconstructions are used if multiplanar and 3D reconstructions are needed (1,2). (See Chapter 1 for more detailed discussion.)
Adrenal Gland
Specific CT Techniques
Scanning should begin at the diaphragm and continue to the pubic symphysis. Noncontrast scans are not routinely performed. However, they may be useful for evaluating the presence of suspected calcifications or hemorrhage, if this information is important for diagnosis. Precontrast imaging can be limited to the region of interest and the milliamperage (mA) and kilovoltage (kV) reduced to the lowest possible that maintain image quality. Contrast-enhanced scanning is usually performed during the portal
P.324

venous phase of imaging, approximately 50 to 60 seconds after the initiation of contrast agent administration (1). This scan timing optimizes not only evaluation of the adrenal glands but also the liver for possible metastases. The start of scanning will be slightly earlier in smaller children. In the latter group of patients, in whom the contrast injection finishes before 50 seconds, the scan delay time needs to be shorter to ensure adequate enhancement of the solid organs. Scanning should start within 10 to 15 seconds of the end of the contrast administration (4).
Most diagnoses can be made from review of the axial image set. Multiplanar reformations in sagittal and coronal planes can be useful for demonstrating the craniocaudal extent of neoplastic, inflammatory, or traumatic lesions and are helpful for displaying the relationship of large adrenal masses to surrounding vasculature (5).
Anatomy
Position
The normal adrenal glands are paired structures that lie within the confines of the perirenal fascia and are surrounded by a variable amount of fat (5,6). The right adrenal gland is situated medial to the right lobe of the liver, lateral to the right diaphragmatic crus, posterior to the inferior vena cava, and anterosuperior to the upper pole of the right kidney. The left adrenal gland lies medial to the spleen, lateral to the left diaphragmatic crus, and posterior to the splenic vessels and the pancreatic tail, and anteromedial to the upper pole of the left kidney. Changes in the normal anatomic relationships may occur as a result of nephrectomy or displacement by adjacent organs, such as liver or pancreas.
Figure 10.1. Normal adrenal glands. A, B: Two CT scans show varying shapes of the adrenal glands (arrows). A: The left adrenal gland anterior to the upper pole of the left kidney has an inverted “V” appearance. B: At a lower level, the left adrenal gland has a triangular shape. The two limbs or the right adrenal gland appear as linear structures medial to the liver.
Shape and Attenuation Value
In the early neonatal period, the borders of the adrenal glands may be convex related to the large amount of fetal cortex. The margins become straight or concave after the first year of life (6).
The adrenal glands usually have medial and lateral limbs extending posteriorly from a central fusion site. Thus, they appear as inverted Y- (Fig. 10.1A) or V–shaped structures lying above the upper pole of the kidneys. In some individuals, the adrenal glands may have a triangular (Fig. 10.1B) or linear shape (2). The right adrenal gland may appear as a single linear structure paralleling the diaphragmatic crus (Fig. 10.lB). This occurs when the lateral limb of the gland is closely apposed to the liver and only the medial limb is seen.
On precontrast CT scans, the adrenal glands have soft tissue attenuation similar to that of the liver. Considerable enhancement can be seen on scans obtained immediately after the administration of intravenous contrast material. This enhancement decreases rapidly, and on subsequent scans, the attenuation of the adrenal gland is equal to or slightly less than that of liver. Intense enhancement that persists on more delayed imaging can be seen in the hypovolemic shock syndrome (7). The adrenal cortex and medulla cannot usually be differentiated by CT scanning.
Size
In neonates and infants, the adrenal glands are relatively large structures, up to one third the size of the kidneys (5,6). During fetal and early postnatal development, the adrenal cortex is composed of two layers: a thick, inner
P.325

fetal cortex, constituting approximately 80% of the gland at birth, and a thin, outer zone, which becomes the adult cortex (8). The bulk of the fetal cortex is responsible for the relatively large size of the adrenal glands at birth. The fetal cortex begins to regress early in the neonatal period, and involution usually is complete within the first year of life. The adrenal glands usually reach full maturation and regain their birth weight by the third year of life (8). Serial sonography studies have shown a 40% to 50% decrease in size within the first 6 weeks of postnatal life (9).
The limbs of the adrenal glands have a uniform thickness except at the apex of the gland where they unite. Standardized measurements of normal length and thickness of the adrenal limbs on CT have not been determined in large series of children. However, standards for normal adrenal size using sonography have been published (9). In neonates, the adrenal length ranges between 0.9 and 3.6 cm (mean, 1.5 cm), and the thickness ranges between 0.2 and 0.5 cm (mean, 0.3 cm) (10). There is no significant difference in the size of the two glands. In older children and adolescents, the thickness of the adrenal gland should be similar to that of the ipsilateral diaphragmatic crus at the same level.
In general, the presence or absence of adrenal disease can be established by subjectively assessing overall shape, margins, and relative size of the gland. Given the considerable variability in the lengths of the adrenal glands in normal individuals, focal or diffuse enlargement is a more important finding than any measurement. The surface of the adrenal glands should be smooth without nodular protuberances, and the thickness of the limbs should be uniform.
Congenital Anomalies
Congenital absence of the adrenal glands is a rare anomaly. Patients with renal agenesis or ectopy will almost always have an ipsilateral adrenal gland present (5,6). In these patients, the gland is elongated, with a linear shape, and lies either in its expected location or slightly more caudal (11). By comparison, the adrenal glands have a normal appearance in patients who have had a nephrectomy. Other organs, such as bowel, tail of the pancreas, and spleen, may move into the empty space in patients with renal agenesis or nephrectomy.
Developmental abnormalities of the adrenal gland are rare. These include adrenal fusion, ectopic or accessory tissue, and heterotopia (5,6). Adrenal fusion or horseshoe adrenal is usually discovered at autopsy and is associated with other anomalies including asplenia. It is rarely seen at imaging (12). Ectopic or accessory adrenal tissue occurs when fragments of adrenal tissue separate off during development. This ectopic tissue usually lies adjacent to the adrenal gland; however, it may lie elsewhere within the retroperitoneum or extend down to the gonads (8). Adrenal heterotopia occurs when accessory adrenal tissue is incorporated into adjacent viscera including kidney and liver (8).
Pseudotumors
Various normal structures may mimic an adrenal mass. Pseudotumors are more common on the left than on the right (13). They usually appear as a rounded structure in the region of the adrenal gland. Most pseudotumors are due to the presence of an accessory spleen, splenic lobulations, or tortuous splenic vessels associated with portal hypertension, producing a masslike appearance. Scanning after intravenous contrast administration should delineate these structures as pseudotumors. Splenic tissue will have the same attenuation and enhancement pattern as the normal spleen. Vascular pseudotumors can be recognized by their tubular shape and intense enhancement. Occasionally, unopacified bowel, a gastric diverticulum, or the tail of the pancreas may extend into the left suprarenal area, simulating an adrenal mass. The use of oral contrast medium allows these structures to be easily recognized. Sagittal and coronal reformatting, the use of gas-producing agents, and rotating the patient so that the segment of interest is in a nondependent (gas-filled) position are effective means of allowing these pseudotumors to be distinguished from true adrenal masses.
Lesions that may simulate an adrenal mass on the right side include an exophytic hepatic mass and interposition of fluid-filled colon into the hepatorenal space. An exophytic renal mass on either side may also mimic an adrenal mass. Other extra-adrenal suprarenal masses include extralobar sequestration (Fig. 10.2) and gastric duplication cysts (14).
Figure 10.2. Sequestration. Coronal multiplanar CT image shows a soft tissue mass in the left suprarenal area. The anomalous vascular supply (arrows) from the aorta helps to establish the diagnosis of pulmonary sequestration rather than a neurogenic tumor.
P.326

Adrenal Masses
Adrenal masses may be caused by neoplasms, hemorrhage, abscesses, and cysts. Adrenal neoplasms may arise from either the adrenal medulla or the cortex. Neoplasms arising in the adrenal medulla include neuroblastoma, ganglioneuroblastoma, ganglioneuroma, and pheochromocytoma. Adrenal cortical neoplasms include adrenocortical carcinoma and adenoma.
Neoplasms of the Adrenal Medulla
Neuroblastoma
Clinical Features
Neuroblastoma is the most common solid, extracranial malignant tumor in children, accounting for 8% to 10% of all childhood cancers (15,16,17,18,19,20). Most children with neuro-blastoma are between 1 and 5 years of age, with a median age at diagnosis of 22 months. Neuroblastomas arise anywhere along the sympathetic nerve chain. In ≤75% of patients, the tumor arises in the abdomen with one half to two thirds of these arising in the adrenal medulla; the remaining abdominal tumors originate in the paravertebral sympathetic ganglia, organ of Zuckerkandl, or pelvis. Sites of metastases are cortical bone and bone marrow, local and distant lymph nodes, liver, and skin. Neuroblastoma has been associated with neurofibromatosis type I and with aganglionosis of the colon, and rarely it is associated with Beckwith–Wiedemann syndrome (16,17,20).
Patients with neuroblastoma may present with clinical complaints related to the primary tumor, distant disease, or a paraneoplastic syndrome. Most patients present with a palpable abdominal mass (15,16,17,18,19,20). At least 70% of patients will have disseminated disease at the time of diagnosis. Signs and symptoms related to metastatic disease include hepatomegaly, bone pain, proptosis, and periorbital ecchymosis. Paraneoplastic syndromes associated with neuroblastoma include opsoclonus-myoclonus syndrome and intractable diarrhea. The opsoclonus-myoclonus syndrome, also referred to as myoclonic encephalopathy of infants, is characterized by acute cerebellar and truncal ataxia and random eye movements (“dancing eyes”) (21,22). These deficits are thought to be due to antineural antibodies against the primary tumor that cross-react with neural cells in the cerebellum or elsewhere in the brain. Intractable watery diarrhea associated with hypokalemia and dehydration is a result of tumor secretion of vasoactive intestinal peptide (VIP) (23).
The minimum criteria for establishing the diagnosis of neuroblastoma are biopsy of tumor tissue demonstrating unequivocal neuroblastoma cells or a combination of positive bone marrow aspirate and increased urinary catecholamine metabolites (vanillylmandelic acid and homovanillic acid).
The most widely used staging system for neuroblastoma is the International Neuroblastoma Staging System (INSS) which is, based on a combination of clinical, radiographic and surgical findings (24) (Table 10.1). Distribu-tion of stages based on the INSS is approximately as follows: I: 20%, II: 10%, III: 15%, IV: 50%, IVS: 4% (16,20).
Table 10.1 International Neuroblastoma Staging System
Stage I
Localized tumor confined to the area of origin; complete gross excision, with or without microscopic residual; identifiable, and contralateral lymph nodes negative microscopically
Stage IIA
Unilateral tumor with incomplete gross excision; ipsilateral nonadherent and contralateral lymph nodes negative microscopically
Stage IIB
Unilateral tumor with complete or incomplete gross excision; positive ipsilateral nonadherent lymph nodes; identifiable contralateral lymph nodes negative microscopically
Stage III
Tumor infiltrating across the midline (defined as contralateral aspect of the vertebral column) with or without regional lymph node involvement; or unilateral tumor with contralateral regional lymph node involvement; or midline tumor with bilateral regional lymph node involvement or extension by infiltration
Stage IV
Dissemination of tumor to distant lymph nodes, bone, bone marrow, liver, and/or other organs (except as defined in stage IVs)
Stage IVs
Localized primary tumor as defined for stage I or II with dissemination limited to liver, skin, and/or bone marrow (<10% tumor) in infants younger than 1 year
From Brodeur GM, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993;11:1466–1477, with permission.
The treatment of neuroblastoma varies with the stage of the tumor (16,17,20). Patients with tumors that are localized to one side of the midline or cross the midline without encasement of major vessels undergo primary surgical resection. Chemotherapy is the treatment of choice in patients with initially unresectable disease. The use of radiation therapy is limited to patients with localized disease that cannot be resected and does not regress completely with chemotherapy. If unresectable tumors decrease sufficiently in volume, delayed surgical resection is performed.
The principal morphologic parameters that influence patient survival are the stage and site of the tumor and patient age. Tumors with lower stages, those arising at extra-abdominal sites, and tumors occurring in children younger than 1 year of age have a more favorable prognosis. Stage is a particularly important factor. Two-year survival ranges from 80% with disease limited to the adrenal to <5% for disease with skeletal metastases (16,20). Several biological markers of tumor tissue also influence survival rate. Favorable factors include triploid karyotypes, well-differentiated stroma, and absence of
P.327

abnormalities of chromosome 1. Expression of the Myc-N oncogene has been found to correlate with worse prognosis and aggressive tumor behavior in children older than 1 year (16,20,25).
Imaging Features
Imaging is important in the diagnosis and staging of neuroblastoma (15,17,18,19). Sonography is sensitive for detecting the primary tumor, but it tends to underestimate the extent of disease. After the presence of an abdominal mass has been confirmed by sonography, patients undergo further imaging with either CT or MRI (26,27). MRI can provide information comparable to that provided by CT about the local extent of disease, but MRI including whole body MRI may also provide valuable information about bone marrow involvement, an area where CT is limited (28,29,30).
Figure 10.3. Neuroblastoma. A–C: CT scans in a 2-year-old girl show a large soft tissue mass with coarse calcifications in the right suprarenal area. The tumor compresses and displaces the right kidney and extends to but does not cross the midline. Pathologically proven stage II tumor.
At CT, neuroblastoma appears as a large irregular extrarenal mass without a definable capsule (15,17,18,19). In older infants and children, neuroblastomas have predominantly soft tissue attenuation, equal to or slightly lower than that of muscle. Scattered low-attenuation areas, representing regions of necrosis or hemorrhage, are common as are calcifications, which are found in about 85% of abdominal neuroblastomas (Fig. 10.3). Tumoral calcification may appear coarse, finely stippled or ringlike. Neuroblastomas
P.328

usually exhibit mild heterogeneous enhancement after intravenous administration of contrast medium.
Figure 10.4. Neonatal neuroblastoma. Axial (A) and coronal (B) reformatted contrast-enhanced CT scans show a cystic appearing mass (M) in the right suprarenal area. The right kidney is displaced inferiorly by the mass. LK, normally positioned left kidney. (Case courtesy of Armed Forces Institute of Pathology.)
In neonates, the tumor has a propensity to undergo hemorrhagic necrosis or degeneration, and thus, often has a cystic appearance. Central necrosis may be so extensive as to simulate a cyst (Fig. 10.4) (31,32,33). Calcification is uncommon in cystic tumors.
Locally, the tumor may extend across the midline, encase and displace vessels, or invade the spinal canal, kidney, or liver (Figs. 10.5 and 10.6) (15,17,18,19). Hepatic metastases and renal atrophy also may be seen. Renal atrophy may result from infarction owing to encasement or compression of the renal vessels by the primary tumor, or follow surgical trauma, chemotherapy, or radiation therapy. Ascites and vena caval thrombus are other features of neuroblastoma (34,35).
Figure 10.5. Neuroblastoma. A: Midline extension and vessel encasement (stage III). Axial (A) and coronal (B) multiplanar CT scans show a large soft tissue mass, with areas of necrosis, crossing the midline and encasing and anteriorly displacing the aorta (black arrows) and inferior vena cava (white arrow). It also displaces the left moiety of a horseshoe kidney anterolaterally.
CT has been used to assess the response of the tumor to surgery, chemotherapy, and radiation therapy.
P.329

Neuroblastoma tends to regress in size with treatment, although the regression may be incomplete, leaving a residual retroperitoneal soft tissue mass.
Figure 10.6. Neuroblastoma with spinal invasion. A left-sided paravertebral neuroblastoma with coarse calcifications displaces the left kidney (K) laterally and extends through the neural foramen into the spinal canal (arrow). Of note, neuro-blastomas in a paravertebral location are more likely to invade the spinal canal than are suprarenal tumors.
Ganglioneuroblastoma and Ganglioneuroma
Ganglioneuroblastoma is a malignant tumor containing both primitive and differentiated cells. Ganglioneuroma is a benign completely differentiated tumor composed of mature ganglion cells. Ganglioneuroblastoma and ganglioneuroma tend to occur later in the first decade of life or in the second decade of life (16,17,20). They have imaging findings similar to those of neuroblastoma and appear as soft tissue–attenuation masses with areas of calcification (Figs. 10.7 and 10.8). The diagnosis is made histologically by the degree of cellular maturation and differentiation.
Pheochromocytoma
The term pheochromocytoma is generally reserved for functionally active neoplasms of the adrenal medulla that cause catecholamine overproduction. When a catecholamine-secreting tumor arises in an extra-adrenal location, it is more properly labeled a paraganglioma (36). Approximately 90% of childhood pheochromocytomas are benign; the remainder are malignant (37,38). Affected patients typically present with hypertension, which is often paroxysmal. Other findings include headache, tachycardia, palpitation, diaphoresis, and pallor (37). Patients with bladder wall paragangliomas may also present with micturition syncope. There is an increased incidence of pheochromocytomas in patients with multiple endocrine neoplasia (MEN) syndromes, usually MEN type 2 (medullary thyroid carcinoma and parathyroid disease), and in patients with tuberous sclerosis, Sturge–Weber syndrome, neurofibromatosis, and von Hippel–Lindau disease (37). Multiple or bilateral tumors are more likely in these syndromes.
Figure 10.7. Ganglioneuroblastoma. Axial CT scan shows a large soft tissue mass (arrows) in the right paravertebral area crossing the midline. Tissue sampling is required to differentiate between neuroblastoma and ganglioneuroblastoma.
The diagnosis of pheochromocytoma is usually established by biochemical testing, which demonstrates elevated urinary or serum catecholamine levels or their metabolites. CT plays a role in tumor localization for surgical planning.
Figure 10.8. Retroperitoneal ganglioneuroma. CT shows a well-defined, smoothly marginated, low-attenuation mass with a small fleck of calcification in the left paravertebral area. A hypoattenuating matrix is typical of mature neural tumors.
P.330

Approximately 70% to 75% of catecholamine-secreting tumors in children arise in the adrenal medulla; ≤30% are extra-adrenal. Retroperitoneal paragangliomas can arise in suprarenal, renal hilar, or infrarenal locations, the latter lesions arising in the organ of Zuckerkandl. Paragangliomas also can be found in the neck, mediastinum, and the wall of the urinary bladder (37).
Pheochromocytomas are usually large masses, generally >2 cm in diameter, at presentation (38). Smaller tumors usually have homogeneous soft tissue attenuation and smooth margins, whereas larger tumors tend to be heterogeneous, necrotic, and poorly marginated (Fig. 10.9) (36,38,39). Central necrosis and punctate calcifications may be present (39). Moderate to intense enhancement after administration of intravenous contrast medium is typical. Signs of malignancy, such as local invasion, lymph node enlargement, and distant metastases, may also be seen.
Plasma catecholamine levels have been reported to be increased by the intravenous administration of iodinated contrast medium, although symptomatic hypertensive episodes do not usually result. This does not appear to be a significant concern now with the more widespread use of nonionic contrast agents (40).
Adrenocortical Diseases
Imaging Evaluation
Neoplasms of the adrenal cortex are rare in childhood (41). Most occur in children with no underlying disorders. However, adrenocortical neoplasms have been reported in association with Beckwith–Wiedemann syndrome. The most common neoplasm associated with this syndrome is Wilms tumor, followed by adrenocortical carcinoma and hepatoblastoma (42). In addition, Beckwith–Wiedemann syndrome can be accompanied by nonneoplastic enlargement of the adrenal glands owing to cortical hyperplasia.
Figure 10.9. Pheochromocytoma in a 10-year-old girl with hypertension and a systolic blood pressure >200 mm Hg. Axial (A) and coronal (B) multiplanar contrast-enhanced CT scans show a left adrenal mass (arrows) with central necrosis. The soft tissue components show relatively intense enhancement.
Most adrenocortical neoplasms are metabolically active and hyperfunctioning; they may be benign or malignant. Nonfunctioning tumors are uncommon and present as palpable abdominal masses. CT is performed in children with functioning and nonfunctioning adrenal lesions to distinguish between hyperplasia and a focal mass and to determine the location of a mass if present. Data are sparse in children, but the accuracy of CT for diagnosis of adrenal masses in adults appears to be >90% (36). Although CT can detect a morphologic abnormality, the CT findings are not specific, so correlation of imaging findings with biochemical tests is needed for a specific histologic diagnosis.
Adrenal Carcinoma
Adrenal carcinoma is a rare, highly malignant neoplasm of the adrenal cortex. The tumor commonly causes virilism in girls and pseudoprecocious puberty in boys (41,42). Cushing syndrome, feminization, and hyperaldosteronism are less common presentations. Mean patient age at diagnosis is 9 years. Biochemical criteria for diagnosis of a virilizing tumor are elevated levels of urinary 17-ketosteroids and normal to mildly elevated urinary cortisol levels.
P.331

Figure 10.10. Adrenal carcinoma in an adolescent girl with virilization. Axial (A) and coronal (B) multiplanar CT images reveal a large, heterogeneous, left suprarenal mass (M) with smooth walls and central necrosis, displacing the splenic vein anteriorly and left kidney (K) inferiorly.
Adrenal carcinomas are usually large heterogeneous masses, measuring >5 cm in diameter, at the time of presentation. Areas of low attenuation, resulting from necrosis and hemorrhage, are found in about 60% of tumors (Fig. 10.10). Calcifications are seen in about 70% of tumors. Mild contrast enhancement is typical (41,43,44). Locally, the tumor may invade the inferior vena cava or liver (41,45,46). Distant metastases are to lung and liver. Fluoro-deoxyglucose (FDG)–positron emission tomography (PET)/CT may be helpful in defining recurrent tumor (47).
Cushing Syndrome
Cushing syndrome is the result of overproduction of adrenocorticotropic hormone or aldosterone (48). Most cases of Cushing syndrome in children are iatrogenic or the result of excess adrenocorticotropic hormone (ACTH) production, resulting from a pituitary or adrenal adenoma (ACTH-dependent disorder). The dexamethasone suppression tests can help in distinguishing pituitary from ectopic causes of elevated ACTH. Urinary cortisol excretion is suppressed in children with pituitary ACTH secretion, but not in children with ectopic ACTH production owing to autonomously functioning adrenal tumors. Less commonly, Cushing syndrome is due to a carcinoma or rarely to adrenal hyperplasia.
Characteristic clinical features include acne, striae, emotional lability, fatigue, obesity, muscle wasting, virilism, hypertension, growth failure, and elevated urinary cortisol and other metabolites. In children with Cushing syndrome caused by carcinoma, the urine 17-ketosteroids and 17-hydroxycorticoids may be elevated.
CT is performed in patients with Cushing syndrome to identify a tumor or hyperplasia. Adrenal adenomas resulting in hypercorticalism are usually homogeneous, smooth, round or oval masses, ranging between 2 and 5 cm in diameter (36,48). Most often they have soft tissue attenuation, but they may have near-water attenuation because of high intracytoplasmic lipid content. They exhibit minimal to mild enhancement after intravenous contrast administration and rapid washout, >50% from baseline attenuation in 15 minutes (48). The contralateral adrenal gland is often small or atrophied secondary to suppression from excess cortisol production.
Primary adrenal hyperplasia causing Cushing syndrome results in diffuse thickening of the adrenal glands, which retain their normal shape. The margins of the adrenal glands are usually smooth, but they may be nodular (48) (Fig. 10.11) The nodules are usually <5 mm, but they can be several centimeters in diameter (48).
Primary pigmented nodular adrenocortical disease is a rare cause of Cushing syndrome. Cortisol levels are elevated, but ACTH levels are low (49). The disorder is associated with Carney complex (skin pigmentation, cardiac and soft tissue myxomas, and Sertoli cell tumors of the testis) (49). CT usually shows multiple, bilateral adrenal nodules measuring between 2 and 5 millimeters; however, they can be up to 3 cm in diameter (48,49). The cortex between the nodules is atrophic, unlike nodular hyperplasia owing to ACTH production, in which the adrenal glands are diffusely thickened (49).
P.332

Figure 10.11. Cushing syndrome owing to adrenal hyperplasia. Bilaterally enlarged, smoothly marginated adrenal glands (arrows) are seen on CT.
Primary Aldosteronism
Primary aldosteronism (Conn syndrome) results from overproduction of the mineralocorticoid aldosterone. Most cases in children are due to idiopathic adrenal hyperplasia rather than to an autonomous aldosterone-secreting adenoma (aldosteronoma). Affected patients typically present with hypertension. Biochemical criteria for the diagnosis of primary aldosteronism include low plasma renin levels, increased plasma aldosterone levels, hypokalemia, and the inability to suppress aldosterone excretion with infusions of normal saline.
At CT, aldosteronomas are typically smaller than cortisol-producing adenomas; most measure <2 cm in diameter (50,51,52). They usually are round or oval and homogeneous. Because of their relatively high lipid content, they can have attenuation similar to that of water. Primary hyperplasia causing aldosteronism produces diffusely thickened adrenal glands. On occasion, a multinodular appearance may be seen (52).
Congenital Adrenal Hyperplasia
Congenital adrenal hyperplasia describes a group of autosomal recessive disorders characterized by enzyme defects in the pathway of cortisol and aldosterone synthesis (8). There is excess production of androgens (53). Most cases are due to 21-hydroxylase deficiency followed by 11-B-hydroxylase deficiency. Clinical manifestations are virilism in girls, premature masculinization in boys, advanced somatic development, and salt wasting. Prenatally and in newborns, the adrenal glands are typically enlarged, although they may be normal in size (54). In older children with untreated congenital adrenal hyperplasia, the adrenal glands may also appear nodular (8,55). Testicular adrenal rests are commonly encountered in this disorder and may be bilateral (55). These lesions appear as round, low attenuation testicular masses.
Miscellaneous Adrenal Neoplasms
Rare adrenal tumors include myelolipoma, hemangioendothelioma, and extramedullary hematopoiesis (56,57,58). Myelolipoma contains varying amounts of fat and bone marrow elements (Fig. 10.12). On CT, most are well marginated; nearly all contain fat, which is an important diagnostic clue to the diagnosis, because with the exception of teratoma virtually no other adrenal lesion contains fat. Hemangioendothelioma typically shows intense contrast enhancement. Extramedullary hematopoiesis appears as a well circumscribed mass with soft tissue attenuation. It usually is associated with hemolytic anemias or chronic myeloproliferative diseases.
Adrenal Hemorrhage
Adrenal hemorrhage is more common in neonates than in older children. In neonates, hemorrhage is usually secondary to birth trauma or perinatal anoxia, but it has been seen in the setting of overwhelming septicemia and anticoagulation therapy (5,6). Affected newborns present with a palpable abdominal mass, jaundice, and anemia. Adrenal insufficiency does not develop, because the major insult is to the regressing fetal cortex rather than to the adult cortex. Sonography is the examination of choice in neonates suspected of having adrenal hemorrhage. When the diagnosis is equivocal, CT can be helpful to document the presence of blood, based on characteristic attenuation values.
P.333

Figure 10.12. Adrenal myelolipoma in a child with thalassemia and a dense liver from secondary hemosiderosis. There is a low-attenuation, right suprarenal mass (arrows) with calcification.
The primary diagnostic problem in the neonate is congenital neuroblastoma presenting as a complex or cystic mass without evidence of metastatic disease. In general, masses owing to adrenal hemorrhage decrease in size rather quickly and disappear in several weeks, whereas the size of a neuroblastoma is unlikely to decrease. Serial imaging with sonography is an acceptable method of separating the two lesions if clinical and laboratory data are not diagnostic.
Adrenal hemorrhage in the older infant and child is usually due to abdominal trauma, but it also can occur as a complication of anticoagulation therapy or overwhelming infection, especially infection caused by Neisseria meningitides. Posttraumatic hematomas are usually unilateral, more often on the right than the left side, and commonly associated with hepatic and splenic lacerations (59,60,61). Most are asymptomatic and detected on CT studies performed for evaluation of other abdominal injury.
Orthotopic liver transplant is another cause of adrenal hemorrhage. In this procedure, a segment of the recipient's inferior vena cava is excised, requiring ligation and division of the right adrenal vein, which can result in infarction and sometimes hemorrhage in the right adrenal gland (62).
CT Findings of Blood
On non-contrast CT, acute hemorrhage may appear denser than adjacent soft tissues. On contrast-enhanced CT, acute hemorrhage appears as a nonenhancing mass (Fig. 10.13). As the hemorrhage liquefies, the attenuation decreases. Over time, the attenuation again increases as the hematoma calcifies. Calcification begins peripherally and proceeds centrally. Eventually, the area of calcification shrinks and assumes the triangular shape of the gland.
Figure 10.13. Adrenal hematoma. Neonate with an echogenic adrenal mass noted on sonogram obtained several days earlier. On CT, a low attenuation mass (arrow) is seen in the right suprarenal area. Decreasing size and calcification were shown on follow-up imaging. K, kidney.
Figure 10.14. Adrenal cyst. Note the well-marginated, round, water attenuation mass (arrow) in the left suprarenal area.
Other Adrenal Lesions
Adrenal cysts and abscesses are uncommon adrenal lesions in childhood (5,6). Adrenal cysts may be true cysts, lined by epithelium, or pseudocysts, which lack an endothelial lining. Pseudocysts result from prior hemorrhage or infection, often parasitic in origin (63). At CT, adrenal cysts are well circumscribed, round, and of near-water attenuation (Fig. 10.14). Higher attenuation, septations, fluid–fluid levels, and wall calcification may be seen in the presence of hemorrhage or infection (63). Multilocular adrenal cysts have been reported with hemihypertrophy and Beckwith–Wiedemann syndrome (64).
Wolman disease is a cause of bilateral adrenal enlargement. This familial disorder of lipid metabolism results in the accumulation of cholesterol esters and triglycerides in most tissues of the body. Affected patients have enlarged adrenal glands with bilateral calcifications (Fig. 10.15) (65). Differential considerations for adrenal calcifications include adrenal teratoma (66), neuroblastoma, ganglioneuroma, cyst, carcinoma, and pheochromocytoma.
Pancreas
CT has a role in the evaluation of complicated pancreatitis, masses, and trauma (67,68,69).
Specific CT Technique for Pancreas
Initial noncontrast scans are generally not needed in pancreatic CT examinations but may be obtained using low
P.334

radiation exposure techniques to identify calcifications or suspected hemorrhage. Scanning for evaluation of trauma and pancreatitis is usually performed during the portal venous phase of imaging (50- to 60-second delay, with shorter delays in smaller patients) (5). In the evaluation of a known or suspected pancreatic mass, thin section scanning in the pancreatic parenchyma phase (30- to 35-second delay) followed by scanning in the portal venous phase can be useful in detecting and localizing hypovascular masses, whereas scanning during the arterial phase (15- to 20-second delay) may help to identify hyperenhancing lesions, such as neuroendocrine tumors, and to evaluate critical arterial structures (70,71). Portal venous phase imaging usually begins at the level of the diaphragm and extends to the pubic symphysis. Arterial and parenchymal phase imaging is limited to the pancreas and peripan-creatic area.
Figure 10.15. Wolman disease in a neonate. Both adrenal glands are enlarged and heavily calcified. Note also hepatomegaly. (Case courtesy of the Armed Forces Institute of Pathology.)
Anatomy
Gross Morphology
The normal pancreas has an oblique orientation, extending from the second portion of the duodenum to the splenic hilum, and is subdivided into four segments: the head, neck, body, and tail. The head lies medial to the second segment of the duodenum, posterior to the gastric antrum, to the right of the superior mesenteric vein (SMV) and anterior to the inferior vena cava (IVC). The uncinate process is a medial and caudal extension of the pancreatic head, lying dorsal to the SMV and superior mesenteric artery (SMA). The neck, the narrowest portion of the pancreas, lies to the left of the head and ventral to the portal vein. The pancreatic body lies posterior to the stomach and anterior to the superior mesenteric artery and vein. The tail is located next to the splenic hilum, anterior to the splenic vein and posterior to the stomach. The most distal portion of the tail lies within the splenorenal ligament, where it becomes intraperitoneal for a short distance.
The body and tail of the pancreas are located anterior or anterolateral to the left kidney. When the left kidney is absent or ectopic, the pancreatic body and tail may be displaced medially and posteriorly, filling the evacuated renal fossa.
Several anatomic relationships are particularly important for understanding the spread of disease. The pancreas lies in the anterior pararenal space, which is contiguous with the anterior renal fascia, the perirenal space and the posterior pararenal space (Fig. 10.16). The stomach lies anterior to the pancreas and is separated from it by the parietal peritoneum and lesser sac. The transverse mesocolon courses along the ventral surface of the pancreas. These relationships become important in acute pancreatitis, as the retroperitoneal and peritoneal communications can serve as pathways for the extension of inflammatory exudate.
The pancreas is closely associated with the splenic vein and artery. The splenic vein lies along the dorsal surface of the body and tail of the pancreas, joining the superior mesenteric vein at the level of the pancreatic neck to form the portal vein. The splenic vein is caudal to the splenic artery. The significance of these anatomic relationships becomes important in patients with tumors or acute
P.335

pancreatitis, as both of these conditions may involve adjacent vessels, causing thrombosis, stenosis, or occlusion.
Figure 10.16. Retroperitoneal anatomy. The anterior pararenal space (horizontal lines) lies anterior to the anterior renal fascia and contains the pancreas (Panc), duodenum (D), and ascending (AC) and descending (DC) colon. The perirenal space (dotted area) lies between the anterior renal fascia and posterior renal fascia and contains the kidneys (K). Posterior pararenal space (cross-hatched lines) lies behind the posterior renal fascia. (Reprinted from
Meyers MA. The extraperitoneal spaces: normal and pathologic anatomy. In: Meyers MA, ed. Dynamic Radiology of the Abdomen: Normal and Pathologic Anatomy. 4th ed. New York: Springer-Verlag; 1994:219–342, with permission.
)
Figure 10.17. Normal pancreas. Arterial phase CT scan. The attenuation of the pancreas (white arrows) greater than that of adjacent liver. Note the main pancreatic duct (approximately 1 mm in diameter) (black arrows) within the pancreatic body, and the homogeneous soft tissue attenuation and smooth borders of the pancreas. Note also the close relationship of the pancreas to the left kidney and stomach (St).
CT Anatomy
In children, the normal noncontrasted pancreas is usually homogeneous and has soft tissue attenuation similar to unenhanced liver. Fatty replacement is unusual and, when encountered, suggests an underlying pancreatic disorder, such as prior pancreatitis or cystic fibrosis. The surface of the pancreas can be either smooth or lobulated, the former being more common. Following administration of intravenous contrast agent, the pancreas shows uniform enhancement. In the arterial phase, enhancement may be more intense than liver (Fig. 10.17).
Figure 10.18. Pancreatic ductal anatomy, common variations. A: Communicating ductal drainage. The dorsal and ventral ducts have fused, so that drainage is through the duct of Wirsung at the major papilla and also through the duct of Santorini at the minor papilla. B: Single-duct drainage. The dorsal and ventral ducts have fused, but the duct of Santorini has not established a communication with the duodenum. The main pancreatic duct drains through the duct of Wirsung at the major papilla. C: Noncommunicating ductal drainage (pancreas divisum). The dorsal and ventral ducts have not fused. Thus, the dorsal pancreas drains through the minor papilla and the ventral pancreas drains through the major papilla. (Adapted from
Schulte SJ. Embryology, normal variation, and congenital anomalies of the pancreas. In: Freeny PC, Stevenson GW, eds. Alimentary Tract Radiology. St. Louis, MO: Mosby; 1994:1039–1051.
)
Part or the entire main pancreatic duct may be seen with thinly collimated, contrast-enhanced CT scans. The duct ranges in diameter from 1 to just less than 3 mm and appears as a linear near-water-attenuation structure.
Pancreatic size increases with increasing patient age, with the most substantial growth occurring in the first year of life. Although reports of pediatric pancreatic size on CT are limited, standards have been established on sonography (72). In general, the pancreatic head and tail are similar in size and are separated by a thinner neck and body. The cephalocaudal dimension of the body and tail ranges from 2 to 4 cm, whereas the dimension of the head may range from 2 to 6 cm, varying with body habitus and size.
Developmental Variants and Anomalies
Ductal Anatomy
The pancreas develops from dorsal and ventral primordia that arise from the caudal part of the developing foregut. The ventral bud gives rise to a portion of the pancreatic head and to the uncinate process. The dorsal pancreas gives rise to the remaining pancreatic head, as well as the body and tail. After the pancreatic primordia fuse, the ventral pancreatic duct and the distal portion of the dorsal pancreatic duct join to form the main pancreatic duct (the duct of Wirsung), which drains into the duodenum with the common bile duct at the level of the ampulla of Vater, 1 to 3 cm caudal to the minor papilla (Fig. 10.18) (73,74). The proximal portion of the dorsal duct persists and becomes the accessory duct (duct of Santorini), which drains into the duodenum through the minor papilla.
P.336

In approximately 60% of individuals, the dorsal and ventral ducts fuse as described above, so that there is dual drainage into the duodenum through the ducts of Wirsung and Santorini (Fig. 10.18A). In approximately 30% of individuals, the dorsal and ventral ducts fuse but the duct of santorini does not communicate with the duodenum. The main pancreatic duct drains the pancreas through the duct of Wirsung into the duodenum (Fig. 10.18B). In 5% to 10% of the population, the dorsal and ventral ducts do not fuse, resulting in two separate ductal systems (pancreas divisum) (Fig. 10.18C).
Pancreas Divisum
Pancreas divisum, the most common anatomic variant of the pancreas, results from failure of normal embryologic fusion of the dorsal and ventral pancreatic ducts. The superior-anterior part of the head, body, and tail are drained by the minor dorsal duct of Santorini through the accessory papilla. The smaller posteroinferior part of the pancreatic head and the uncinate process are drained by the major duct, the duct of Wirsung, through the papilla of Vater. Patients with this anomaly may be asymptomatic or present with pancreatitis (73,74,75). In one retrospective review of 135 patients, pancreas divisum was found in 7.4% of patients with acute pancreatitis and in 19.2% with recurrent or chronic pancreatitis (76).
The diagnosis of pancreas divisum can be suggested on CT when separate dorsal and ventral pancreatic moieties are seen or when an isolated ventral duct is identified (73,74,77) (Fig. 10.19). The overall size of the pancreas may be normal or the thickness of the pancreatic head may be increased.
Figure 10.19. Pancreas divisum in a 15-year-old girl with chronic pancreatitis, intermittent jaundice, and two ampulla seen at endoscopic retrograde cholangiopancreatography. Dilated dorsal and ventral pancreatic ducts (arrows) are noted on this portal venous phase CT scan.
Figure 10.20. Annular pancreas. The apparent thickening of the soft tissues (arrowheads) around the duodenum (D) represents the annular pancreas.
Annular Pancreas
In annular pancreas, the ventral primordia encircle the second part of the duodenum, producing a variable degree of duodenal obstruction. This anomaly may be associated with Down syndrome and gastrointestinal anomalies, such as duodenal atresia and duodenal stenosis. On CT, the diagnosis of annular pancreas is suggested when the soft tissues surrounding the descending duodenum appear thicker than normal (Fig. 10.20) (67,68,69,78,79) with an enhancement pattern similar to that of pancreatic parenchyma.
Dorsal Pancreas Agenesis
Agenesis of the dorsal pancreatic moiety is a developmental anomaly in which only the head of the pancreas develops. The CT diagnosis is based on identification of a pancreatic head with absence of pancreatic tissue in the expected locations of the neck, body, and tail (Fig. 10.21) (80). Polysplenia can be an associated finding (81,82). Because most of the islet cells are located in the distal pancreas, patients with this anomaly have an increased risk of diabetes mellitus (83). A case of a dorsal pancreas presenting as a chest mass has been reported in an adult (84).
Ectopic Pancreas
Ectopic pancreatic tissue is defined as pancreatic tissue that lacks a direct or vascular connection to the normal
P.337

pancreas. This is an uncommon condition that usually is asymptomatic and is discovered incidentally on contrast examinations of the gastrointestinal tract (85). On occasion, patients with ectopic pancreas present with abdominal pain, obstruction. or even jaundice. Approximately 70% of these rests are found in the stomach, duodenum, and jejunum. The remainder occur in the ileum, liver, spleen, biliary tract, mesentery, or umbilicus. CT may demonstrate a small mass in a hollow viscus or findings of ductal obstruction (86).
Figure 10.21. Congenital short pancreas in an 8-month-old girl. Coronal multiplanar reconstruction shows a well-defined, round pancreatic head (H). The enhancement is uniform and slightly greater than liver. No pancreatic body or tail was identifiable. Also seen is a right-sided stomach (St), transverse liver, small splenule (arrow), and absence of the intrahepatic portion of the inferior vena cava in this patient with situs inversus, polysplenia syndrome, and an interrupted inferior vena cava.
Figure 10.22. Fatty replacement of the pancreas in cystic fibrosis. A: An 11-year-old girl. Portal venous phase CT shows partial fatty replacement of the pancreas (arrows) with minimal residual glandular tissue. B: A 15-year-old girl. The pancreas (arrows) is completely replaced by fatty tissue. The liver has low attenuation related to fatty infiltration.
Congenital Diseases
Cystic Fibrosis
Cystic fibrosis (CF) is a recessively inherited disease, with an estimated prevalence of approximately 1 per 2,500 births (87). There is impaired epithelial transmembrane ion transport resulting in abnormally thick secretions, which affect not only the lungs but also the liver and pancreas. Affected patients may have pancreatic exocrine and endocrine insufficiency. Pancreatic exocrine dysfunction results from obstruction of the small ductules by mucoid secretions, which causes the acini and ductules to dilate and the glandular tissue to atrophy. Nearly all patients have a degree of pancreatic inflammation (87). Eventually the pancreatic parenchyma is replaced by fibrosis and fat.
The typical CT feature of cystic fibrosis is total or partial fatty replacement of the parenchyma (88,89) (Fig. 10.22). Less common manifestations include calcifications (Fig. 10.23), atrophy, which can occur without fatty replacement (Fig. 10.24), and single or multiple macroscopic (>1 cm) cysts, referred to as pancreatic cystosis (Fig. 10.25) (87,90). Cystosis is thought to be related to ductal inspissation of tenacious secretions, leading to ductal obstruction and ectasia. On CT, these cysts have water attenuation, smooth thin walls, and
P.338

occasionally septations and they may involve the entire gland. Similar cystic changes can be seen in polycystic disease, von Hippel–Lindau disease, and in lymphangiomas; the clinical context usually allows the correct diagnosis (87).
Figure 10.23. Pancreatic calcifications in cystic fibrosis. A: Multiple parenchymal calculi are noted in the pancreatic tail (arrows) on this portal venous phase CT image. B: Numerous large calcifications along with fatty replacement of the pancreas (arrows) are noted in another patient.
Shwachman–Diamond syndrome
Shwachman–Diamond syndrome is an autosomal recessive condition characterized by exocrine pancreatic insufficiency and varying degrees of hematologic and skeletal abnormalities including neutropenia, metaphyseal dysostosis, and dwarfism (91). In Shwachman-Diamond syndrome, pancreatic insufficiency is present at birth. Clinical manifestations include failure to thrive, foul-smelling fatty feces, and short stature. The typical pathologic finding is fatty replacement of the pancreatic parenchyma, commonly total replacement, producing a low-attenuation gland on CT scans (91).
Figure 10.24. Pancreatic atrophy in cystic fibrosis. Portal venous phase CT scan in a 15-year-old girl demonstrates a small atrophied pancreas (arrows) with normal glandular enhancement.
Johnson–Blizzard Syndrome
The Johnson–Blizzard syndrome is characterized by congenital aplasia of the nasal alae, deafness, hypothyroidism, dwarfism, and malabsorption (92). Similar to cystic fibrosis, but in contrast to the Shwachman–Diamond syndrome,
P.339

endocrine dysfunction occurs in this syndrome, and diabetes mellitus will develop in affected patients. Recently a mutation in the CEL gene has been found in patients with the Johnson–Blizzard syndrome (93). The characteristic CT finding is total fatty replacement of the pancreas.
Figure 10.25. Pancreatic cystosis in cystic fibrosis. Portal venous phase CT shows several round cysts in the pancreatic body and tail (arrows). Arrowhead, splenic vein. (Reprinted from
Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006;26: 1211–1238, with permission.
)
Other causes of pancreatic lipomatosis include chronic pancreatitis, steroid therapy, Cushing syndrome, and obstruction of the main pancreatic duct. A specific diagnosis usually can be established based on the combination of clinical and biochemical findings.
Congenital Hyperinsulinism
Congenital hyperinsulinism, previously known as the infantile form of nesidioblastosis, is a rare disorder characterized by a proliferation of hyperfunctioning beta cells, which results in excessive production and release of insulin (94). Congenital hyperinsulinism is associated with recessive mutations of the beta-cell ATP-sensitive potassium channel. Symptoms related to hypoglycemia begin in the first few hours of life and are severe and persistent. Prompt diagnosis and treatment are critical to ensure adequate glucose supply to the developing brain, thus preventing neurologic impairment. Two pathologic forms are recognized: the diffuse form, accounting for two thirds to three fourths of cases, and a focal form accounting for the remaining cases (94,95). In the diffuse disease, there is a widespread increase in islet cells (termed diffuse adenomatosis), whereas in the focal form there is a focal pancreatic lesion (focal adenomatosis). The diffuse form is treated with near-total (95%) pancreatectomy; the focal form is treated with resection of the lesion.
There are few reports of the CT appearance of congenital hyperinsulinism. (94). CT of diffuse congenital hyperinsulinism may be normal or it may demonstrate diffuse enlargement of the pancreas. The CT finding of focal disease is a focal heterogeneous mass (Fig. 10.26). Recent studies suggest that positron emission tomography (PET) scanning using 18-fluoro L-DOPA may be useful to identify focal and diffuse disease (96). Pancreatic regeneration after near-total pancreatectomy has been reported (97).
Acute Pancreatitis
Blunt abdominal trauma remains the leading cause of pancreatitis in children and is most often caused by motor vehicle or bicycle accidents or nonaccidental injury (98). Other causes include systemic diseases (vasculitis and Crohn disease), drug toxicity (valproic acid, L-asparaginase, and corticosteroids), obstructive biliary tract diseases (gallstones, sludge, and biliary ascariasis), surgery, post–endoscopic retrograde cholangiopancreatography (ERCP), viral infection (mumps, coxsackievirus B), and developmental or hereditary disorders. Developmental anomalies include pancreas divisum and duodenal duplication, whereas hereditary diseases include cystic fibrosis and hereditary pancreatitis (98). In pancreas divisum, it has been suggested that the duct of Santorini and the accessory papilla are too small to transmit the increased volume of pancreatic secretions that must flow through them. The result is a relative stenosis at the accessory ampulla and pooling of secretions, leading to pancreatitis. Duodenal duplications may be located next to the duodenum adjacent to the ampulla of Vater or they may arise in the pancreas itself, most often in the pancreatic head and tail (99). Pancreatitis is thought to develop when there is compression of the pancreatic duct by the duplication cyst. The cause of acute pancreatitis is unknown in as many as 30% of children (98).
Figure 10.26. Congenital hyperinsulinism (focal endocrine adenomatosis) of the pancreas in a 1-month-old girl with persistent hypoglycemia and hyperinsulinism. Contrast-enhanced CT reveals a heterogeneous mass in the neck and body of the pancreas (white arrow). Curved arrow, splenic vein. (Reprinted from
Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006;26: 1211–1238, with permission.
)
Classification: Pathologic and Clinical Characteristics
Acute pancreatitis is defined as an acute inflammatory process of the pancreas with variable involvement of adjacent tissues and organs. Acute pancreatitis is further classified as mild or severe based on histologic and clinical findings. Histologically, mild pancreatitis is characterized by minimal interstitial edema and acinar cell necrosis (100). Most patients with mild pancreatitis present with abdominal pain and tenderness, nausea, vomiting, and fever. This is usually a self-limited disease with a rapid response to conservative medical therapy, improvement in clinical and laboratory findings within 48 to 72 hours, and no significant complications.
P.340

Severe acute pancreatitis is associated with major organ failure, including gastrointestinal bleeding and renal and pulmonary insufficiency. Histologic findings are much more extensive than in mild pancreatitis and include macroscopic ductal disruption and areas of intrapancreatic and extrapancreatic fat necrosis. Local complications, such as pseudocyst formation, pancreatic abscess, and necrosis, are common.
Imaging Examinations
The diagnosis of acute pancreatitis is usually established by a combination of clinical findings and biochemical tests (e.g., elevated blood lipase and pancreatic amylase). Occasionally, however, biochemical studies are not specific. CT can be useful to confirm an uncertain clinical diagnosis, evaluate severity of disease, document suspected complications (101,102,103), or guide fine-needle aspiration and catheter drainage (101,104).
CT of Uncomplicated Acute Pancreatitis
In mild acute pancreatitis, the CT appearance of the pancreas may be normal in up to 70% of patients (103). In the remaining patients, CT findings include diffuse or focal glandular enlargement (Figs. 10.27 and 10.28), irregularity of contour, heterogeneous enhancement representing edema or focal necrosis, and extrapancreatic inflammatory changes and fluid collections. In mild pancreatitis, contrast enhancement may be increased or normal; in severe acute pancreatitis, enhancement may be decreased or absent.
Figure 10.27. Acute diffuse pancreatitis. Mild acute pancreatitis in a 2-year-old girl with Crohn disease. Portal venous phase CT shows global enlargement of the pancreas (arrows) with normal glandular enhancement throughout. This patient's symptoms improved substantially within 48 hours.
Figure 10.28. Acute focal pancreatitis in two patients. A: A 9-year-old girl with elevated amylase and lipase levels. Parenchymal phase CT scan shows an enlarged, heterogeneously enhancing pancreatic head (arrows). Also note fluid in the anterior pararenal space (open arrow) and root of the small bowel mesentery (arrowhead). B: A 13-year-old boy with abdominal pain, vomiting, and elevated amylase levels. Portal venous phase CT shows heterogeneous enhancement of the pancreatic tail (arrow). Also note fluid in the left pararenal space and left paracolic gutter.
Complications of Acute Pancreatitis
Acute Fluid Collections
Acute fluid collections are defined as collections of pancreatic juice that occur early in the course of pancreatitis (within 48 hours), are located in or near the pancreas, lack a well-defined capsule, and distend an already existing
P.341

anatomic space (101,103). Intrapancreatic fluid collections occur in <10% of children with acute pancreatitis, whereas extrapancreatic fluid collections occur in ≤50% of children (103). Sites of peripancreatic fluid in descending order of frequency are the anterior pararenal space (71%), lesser sac (57%), lesser omentum (50%), transverse mesocolon (50%) right and left perihepatic spaces (36% each), subphrenic spaces (36%), posterior renal fascia (29%), perirenal space (21%), small bowel mesentery (21%), and lesser and greater omentum (7% each) (103) (Fig. 10.28). Fluid can also extend into the mediastinum and solid organs.
On CT, acute fluid collections are poorly defined and have low attenuation and irregular contours (101,103). They may change in size and shape, and many resolve completely within a few weeks. The absence of a wall is helpful in distinguishing them from pseudocysts.
Pseudocysts
A pseudocyst is a collection of amylase-rich pancreatic juice contained by a wall of fibrous or granulation tissue that typically forms over several weeks (4 to 6 weeks) from an acute fluid collection (98). It is termed a pseudocyst, rather than a true cyst, because it lacks an epithelial lining. Unlike acute fluid collections, which usually resolve spontaneously, resolution of a pseudocyst is less likely when there is a well-formed wall. Some smaller pseudocysts may regress spontaneously when they acquire a communication with the pancreatic duct or bowel. Pseudocysts may produce symptoms owing to rupture into adjacent bowel or the peritoneal cavity, slow intraperitoneal leakage causing ascites, hemorrhage, abscess formation, or obstruction of the gastric outlet or bile ducts (101).
Figure 10.29. Pancreatic pseudocyst complicating acute pancreatitis in a 5-year-old girl treated with asparaginase for acute lymphoblastic leukemia. A: Portal venous phase axial CT scan demonstrates a well-defined homogeneous fluid collection (F) extending anterior to the pancreatic body and tail (black arrows). Inflammatory changes (white arrow) are seen in the left paracolic gutter. B: Coronal multiplanar reformation shows the cyst extending from the stomach (open arrow) to the aortic bifurcation (white arrow). Displacement of the stomach superiorly is also noted.
On CT, pseudocysts appear as well-circumscribed, homogeneous, round or oval fluid collections with near-water attenuation (Fig. 10.29). The presence of high-attenuation areas suggests superimposed hemorrhage or infection (Fig. 10.30). Pseudocysts usually are found adjacent to or within the pancreas, but they may be found in the pararenal space, left lobe of the liver, juxtasplenic area, duodenum (105), retroperitoneum, and mediastinum. Percutaneous catheter drainage is effective for treatment of most pancreatic pseudocysts (98,101,106). Surgical drainage is performed when there is catastrophic bleeding or when the percutaneous access route is considered to be too hazardous for catheter placement.
Pancreatic Abscess and Necrosis
Pancreatic abscess is defined as a walled-off collection of pus located in close proximity to the pancreas (101,107). It may be the result of infection of a pancreatic phlegmon, fluid collection, or pseudocyst. There is little or no pancreatic necrosis. At CT, an abscess appears as a circumscribed fluid collection with attenuation similar to that of water or soft tissue, dependent on the amount of purulent material. Gas bubbles may be present, but they are not specific for infection, and can also be seen in patients with pancreaticoenteric fistulas.
Pancreatic necrosis is defined as a focal or diffuse area of liquefied, nonviable pancreatic parenchyma (101,107). The CT diagnosis is based on demonstration of one or more areas of nonenhancing parenchyma that are >3 cm in diameter or involves ≥30% of the area of the pancreas. Gas bubbles may be present in infected necrosis (Fig. 10.31) (101). CT features of abscess and infected necrosis
P.342

are similar, and aspiration is usually needed for differentiation and for planning clinical management. Abscesses may be drained percutaneously, whereas infected necrosis may require surgical debridement (107).
Figure 10.30. Pancreatic pseudocyst. A: Contrast enhanced portal venous phase CT shows a homogeneous pseudocyst (C) abutting the stomach posteriorly and inflammatory changes (arrow) in the gastrosplenic ligament. B: The patient returned 2 months later with worsening abdominal pain. High attenuation fluid expands the pre-existing pseudocyst posterior to the stomach and it also extends into the left perihepatic and perisplenic spaces. The high attenuation fluid represents bleeding from a pseudoaneurysm.
Vascular Abnormalities
Vascular complications include hemorrhage, pseudoaneurysm formation, and venous thrombosis or occlusion. Acute hemorrhage or pseudoaneurysm formation result when the inflamed pancreas or proteolytic enzymes released in pancreatitis destroy arterial walls. The splenic artery and branches of the pancreaticoduodenal arteries are the most frequently involved vessels (108). CT angiography can be effective in diagnosing the presence of a pseudoaneurysm and defining its extent and origin (108). CT findings of pseudoaneurysm are a homogeneous, densely enhancing mass within or adjacent to the pancreas (Fig. 10.32) or within a pseudocyst. The presence of high-attenuation fluid
P.343

in the peritoneal cavity or retroperitoneum suggests a bleeding pseudoaneurysm (Fig. 10.30) (109). Angiography with embolization is the treatment of choice for pseudo-aneurysm.
Figure 10.31. Infected pancreatic necrosis. Multiple fluid collections containing gas bubbles (arrows) are seen in the head, body, and neck of the pancreas. The patient was successfully treated with surgical debridement.
Figure 10.32. Pseudoaneurysm of the splenic artery. Parenchymal phase CT image just caudal to the pancreatic body shows an enhancing pseudoaneurysm (arrowhead) surrounded by low-attenuation clot. Fluid is noted in the pararenal spaces and lesser sac (LS). D, duodenum.
Splenic, superior mesenteric, or portal venous obstruction results when adjacent inflammatory tissue or a pseudocyst compresses the vein, causing spasm and venous stasis. In some cases, there may be damage directly to the venous wall. Acute thrombosis causes a luminal filling defect or an abrupt cutoff of the involved vein on contrast-enhanced CT. Chronic thrombosis should be considered when there are perigastric or mesenteric varices.
Chronic Pancreatitis
Chronic pancreatitis indicates persistent pancreatic inflammation associated with permanent morphologic changes in the gland and/or functional abnormalities (71). Affected children usually present with recurrent abdominal pain. Most chronic pancreatitis in children is associated with hereditary pancreatitis and pancreaticobiliary ductal anomalies (e.g., pancreas divisum and anomalous insertion of the common bile duct) (98). Hereditary pancreatitis is familial and often an autosomal dominant disorder, characterized by recurrent episodes of acute pancreatitis beginning in childhood and continuing over many years. Several genetic factors are now recognized as potential causes, including mutations within the CFTR gene and the cationic trypsinogen gene (98). Complications include exocrine and endocrine pancreatic insufficiency, pseudocyst formation, and adenocarcinoma of the pancreas. Less common causes of chronic pancreatitis are malnutrition, hyperparathyroidism, and cystic fibrosis. About 10% to 20% of children with acute pancreatitis develop recurrent or chronic pancreatitis (98).
The characteristic CT manifestations of chronic pancreatitis are parenchymal and ductal calcifications, an atrophic gland with or without fatty replacement, and pancreatic or biliary ductal dilatation. Chronic pancreatitis can be associated with pseudocyst formation and splenic and portal venous obstruction (110).
Other rarer causes of chronic pancreatitis are idiopathic fibrosing pancreatitis and autoimmune pancreatitis (111,112,113). Idiopathic fibrosing pancreatitis is associated with a fibrotic process in the pancreatic head, leading to obstruction of the common bile duct (98,112). CT findings of fibrosing pancreatitis include focal pancreatic head enlargement and biliary ductal dilatation (111) (Fig. 10.33).
Autoimmune pancreatitis is associated with elevation of serum IgG levels, autoantibodies to pancreatic antigens, irregular narrowing of the main pancreatic duct, and biliary strictures. There is an association with other autoimmune disorders, such as primary sclerosing cholangitis and systemic lupus erythematosus (113). CT findings of auto-immune pancreatitis include focal or diffuse pancreatic enlargement, delayed enhancement, a low-attenuation rim surrounding the pancreas, and minimal or no peripancreatic inflammation (113). Diagnosis of this disease is important because it is reversible with steroid therapy.
Figure 10.33. Idiopathic fibrosing pancreatitis in a 12-year-old girl. Portal venous phase demonstrates an enlarged pancreatic head (arrows).
Neoplasms
Pancreatic tumors are uncommon in children, accounting for 0.2% of all pediatric tumors (114,115,116,117). They can be divided histologically into epithelial and nonepithelial types, and epithelial tumors may be further classified as exocrine or endocrine (94). Exocrine tumors include pancreatoblastoma, ductal and acinar cell carcinoma, and solid pseudopapillary tumors. Endocrine tumors include nonfunctioning and functioning islet cell tumors (insulinoma, gastrinoma, glucagonoma, VIPoma, and somatostatinoma) and neuroendocrine adenomatosis (congenital hyperinsulinism, see above discussion). Nonepithelial pancreatic tumors arise from the connective, lymphatic, vascular, and neuronal tissues of the pancreas (114,117). Rare cystic neoplasms are microcystic adenoma and mucinous cystic tumor.
Exocrine Tumors
Pancreaticoblastoma
Pancreaticoblastoma is the most common pancreatic tumor of young children (94,115,117). It typically occurs in infancy and early childhood, but occasionally it can be diagnosed in the fetus. Congenital cases have been described in association with Beckwith–Wiedemann syndrome (118). Pancreaticoblastoma is usually a large mass with a mean diameter of approximately 11 cm (94,119). Histologically, it resembles fetal pancreatic tissue at the
P.344

eighth week of development. Approximately half arise in the head of the pancreas (94,114,120). Typical clinical findings include an asymptomatic upper abdominal mass, abdominal pain, vomiting, and rarely, obstructive jaundice. Serum alpha-fetoprotein may be elevated. Invasion of adjacent organs and metastases to liver, regional lymph nodes, peritoneal cavity, and lung may occur. The long-term prognosis is good with complete surgical resection and absence of metastases.
Figure 10.34. Pancreaticoblastoma in a 2-year-old boy with abdominal pain. Portal venous phase CT scan shows a heterogeneous mass (M) in the pancreatic tail displacing contrast-filled bowel loops to the right. The low-attenuation areas represent necrosis.
CT features of pancreaticoblastoma are a large, heterogeneous soft tissue mass that contains septa and/or cystic areas reflecting necrotic or hemorrhagic changes (121,122,123,124,125,126) (Fig. 10.34). Heterogeneous contrast enhancement may be seen.
Adenocarcinoma
Pancreatic adenocarcinoma is a rare pancreatic tumor of ductal or acinar origin, with the former being more common in children (94,127). Average age at time of presentation is 6 years (128). The mean size of the acinar cell carcinoma is 10 cm (94). The common presenting complaint is abdominal pain. Adenocarcinoma of the pancreas is often located in the head or body and tends to be disseminated at the time of diagnosis with poor prognosis. The CT features of the tumor are similar to pancreaticoblastoma, namely a heterogeneously enhancing soft tissue mass that contains hypoattenuating areas representing tumoral necrosis. Calcifications may be present. Pancreatic or biliary ductal dilatation, hepatic metastases, lymphadenopathy, and vascular encasement may also be noted (129).
Solid Pseudopapillary Tumor
Solid pseudopapillary tumor (SPT) of the pancreas (previously known as solid and papillary epithelial neoplasm, solid-cystic papillary tumor, papillary cystic tumor, and Frantz tumor) is a rare tumor with low-grade malignant potential (94). It commonly affects adolescent girls and young women (90%), with a mean age of 22 years (130,131,132,133). Patients typically present with a slowly enlarging upper abdominal mass that may be asymptomatic or produce mild abdominal pain. Jaundice is a rare presenting feature. Laboratory findings are usually normal (94,133). These tumors tend to be large (mean diameter 6 to 11 cm) and can be found throughout the pancreas, although most arise in the tail or head (94,133). Metastases, usually to liver, and local invasion occur in ≤15% of patients (94). Prognosis following surgical resection is excellent (94).
At CT, solid pseudopapillary tumor is large, well circumscribed, and variable in appearance depending on the amount of solid tissue, hemorrhage, and necrotic change. Most tumors are heterogeneous with solid and cystic elements or nearly completely cystic with a small amount of residual solid tissue at the periphery (Fig. 10.35) (94,134,135). Very small tumors may be completely solid and homogeneous. The soft tissue components demonstrate enhancement after contrast administration. Calcifications, usually in the periphery of the tumor, and fluid levels may also be seen.
Neuroendocrine Tumors (Islet Cell Tumors)
Neuroendocrine or islet cell tumors are thought to arise from neuroendocrine cells (71,120). They are classified as functioning (i.e., hormone secreting) or nonfunctioning. Functioning tumors are named for the hormone secreted. Insulinoma and gastrinoma are the most common functioning tumors. Somatostatinoma, VIPoma, and glucagonoma are rarer. Neuroendocrine tumors may be benign or malignant. Most neuroendocrine tumors in children are benign and functioning (94,136,137). They usually appear sporadically, but they can be associated with multiple endocrine neoplasia type I (MEN1) syndrome and von Hippel–Lindau disease.
Functioning Islet Cell Tumors
Symptoms of a functioning neuroendocrine tumor depend on the main hormone produced. Patients with insulinomas present with symptoms of hypoglycemia, high plasma insulin levels, and low blood glucose levels. Insulinomas are usually small (<2 cm in diameter), homogenous, and well circumscribed (138,139,140,141) (Fig. 10.36). Patients with gastrinomas present with abdominal pain, diarrhea, peptic ulcer disease, and elevated serum gastrin levels. Gastrinomas are similar in size to or slightly larger than insulinomas and may have a heterogeneous
P.345

matrix even if relatively small (Fig. 10.37). The other functioning islet cell tumors are frequently large (>5 cm in diameter) and often heterogeneous with foci of cystic change, related to necrosis and hemorrhage, and calcifications (94).
Figure 10.35. Solid and papillary epithelial neoplasm of the pancreas. A: A 15-year-old girl with epigastric pain and weight loss. Parenchymal phase CT scan demonstrates a sharply defined heterogeneous mass (arrows) with minimal amounts of solid tissue in the head of the pancreas. B: CT scan in another 15-year-old girl with abdominal pain shows a predominantly cystic mass (arrows) in the head of the pancreas. The surrounding soft tissue rim is the result of associated pancreatitis.
Because of their small size, insulinomas and gastrinomas often do not alter the pancreatic contour. They are best seen during the arterial phase of contrast enhancement. Typically, these tumors enhance more than normal pancreatic parenchyma and are usually hyperattenuating in the arterial phase (138,139) (Figs. 10.36 and 10.37). Hepatic metastases are also hypervascular.
Figure 10.36. Functioning insulinoma in a 13-year-old boy with recurrent hypoglycemia. Arterial phase CT scan demonstrates a small, intensely enhancing, homogeneous mass (arrow) in the pancreatic neck.
Nonfunctioning Islet Cell Tumors
Nonfunctioning tumors are usually large at the time of diagnosis (>5 cm in diameter) and commonly present with symptoms owing to mass effect, local invasion, or metastatic disease. They usually are heterogeneous and demonstrate cystic change, necrosis, and calcification (140,141)
P.346

(Fig. 10.38). Liver metastases, vascular invasion, and regional lymph node enlargement may also be seen (137).
Figure 10.37. Metastatic gastrinoma in an 8-year-old girl who presented with a several-month history of abdominal discomfort, chronic diarrhea, episodic vomiting, and black stools. Coronal image from an arterial phase CT scan shows a homogeneously enhancing mass in the region of the pancreatic head (black arrows), a small, enhancing mass in the left lobe of the liver (white straight arrow), and thickened gastric folds (curved arrow). (Reprinted from
Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006;26:1211–1238, with permission.
)
Figure 10.38. Nonfunctioning islet cell tumor in an 11-year-old girl with upper gastrointestinal bleeding and weight loss. Portal venous phase CT shows a large heterogeneous mass in the pancreatic head (white arrows), edema (E) in the mesenteric root, and a thickened right colonic wall (black arrow). The colonic wall thickening was related to edema from hypoproteinemia.
Nonepithelial Tumors
The clinical presentation of these tumors includes abdominal mass, pain, and obstructive jaundice.
Inflammatory Pseudotumor
Pancreatic inflammatory pseudotumor or inflammatory myofibroblastic tumor is an uncommon benign mass composed of a localized collection of inflammatory cells, including plasma cells, lymphocytes, eosinophils and mast cells, fibrous stroma, and spindle cells (142,143). On noncontrast CT scans, inflammatory pseudotumors may be hypodense or isodense to muscle. Following administration of intravenous contrast agent, the tumor may show heterogeneous or homogeneous enhancement (142,143). In general, prognosis is excellent following surgical resection, with local recurrence being uncommon.
Lymphoma
Pancreatic involvement by lymphoma is more common in non-Hodgkin lymphoma than in Hodgkin disease (94,144). Lymphomatous involvement may appear as diffuse pancreatic enlargement owing to widespread infiltration (Fig. 10.39) or a focal or multiple, homogenous, hypoattenuating masses. Diffuse enlargement of the gland may also be due to secondary pancreatitis related to tumor lysis syndrome (114,145). Biliary dilatation and secondary pancreatitis are uncommon (146). Associated splenomegaly or retroperitoneal adenopathy can help to establish the diagnosis.
Figure 10.39. Lymphoblastic lymphoma in a 17-year-old boy with epigastric pain and elevated liver function tests and amylase levels. Portal venous phase CT scan shows diffuse, homogeneous enlargement of the pancreas. There is dilation of the common bile duct (arrow) and intrahepatic ducts (arrowheads). (Reprinted from
Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006; 26:1211–1238, with permission.
)
Lymphangioma
Lymphangioma is a benign congenital mass caused by obstruction of fetal lymphatics (121). At pathologic examination, it typically is multicystic and surrounded by a thin capsule; the cystic spaces contain serous or chylous fluid (94). At CT, lymphangioma appears as a unilocular or multilocular, low-attenuation mass with enhancing septa and capsule (121) (Fig. 10.40).
Figure 10.40. Lymphangioma of the pancreas. Portal venous phase CT scan shows cystic masses (white arrows) in the pancreatic body and tail. Low-attenuation mass is also noted in the peripancreatic space (black arrows). Biopsy-proven widespread lymphangiomatosis.
P.347

Figure 10.41. Mature teratoma of the pancreas in a 21-year-old woman who presented with a long history of nonspecific abdominal pain. A, B: Two portal venous phase CT scans show a complex mass with foci of fat (asterisk) and calcification (small arrows), and a large cystic component (large arrows, B). At operation, the tumor arose in the body of the pancreas. (Reprinted from
Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006;26:1211–1238, with permission.
)
Teratoma
Cystic teratoma develops from pluripotential cells of the embryonic remnants of the ectoderm (147,148,149). CT findings include a predominantly cystic mass with varying amounts of fat, calcification, bone, and soft tissue (147,148,149,150) (Fig. 10.41).
Other Mesenchymal Tumors
Rare malignant tumors include primitive neuroectodermal tumor (PNET) (151), rhabdomyosarcoma (152), malignant schwannoma, fibrosarcoma, liposarcoma, and malignant fibrous histiocytoma (69). At CT, these tumors are large and often heterogeneous with cystic or necrotic areas (Fig. 10.42). Rare benign lesions include hemangioendothelioma (153), leiomyoma, lipoma, neurofibroma, and schwannoma.
Rare Cystic Neoplasms
Cystic pancreatic neoplasms are extremely rare in children, with most occurring in older adult women. They are of two types: microcystic adenoma and mucinous cystic neoplasm. Microcystic adenoma, also known as serous cystadenoma, has no malignant potential (71,120). At CT, microcystic adenomas can be of water, soft tissue, or mixed attenuation and are usually composed of numerous cysts, typically <2 cm in diameter. However, some may contain larger cysts. The tumor often has a lobulated contour, thin capsule, and absent wall enhancement (71,120). This is one of the pancreatic lesions found in patients with von Hippel–Lindau disease.
Mucinous cystic neoplasm, previously known as macrocystic adenoma, mucinous cystadenoma, or cystadenocarcinoma, has malignant potential. CT findings are a near-water-attenuation, unilocular or multilocular cystic mass. Multilocular lesions usually contain six or fewer cysts that tend to be >2 cm in diameter (71,94,154). The cyst walls may be irregular with nodular excrescences.
Pancreatic Cysts
Cystic lesions of the pancreas may be congenital or acquired. True congenital cysts are epithelial lined and
P.348

thought to be due to the abnormal sequestration of primitive pancreatic ducts. They are generally asymptomatic and found incidentally, although abdominal distension, vomiting, jaundice, or pancreatitis have been reported. They are most often found prenatally or in children younger than 2 years or age, but they may be seen at any age (148,155,156). At CT, congenital cysts appear as thin-walled, unilocular or multilocular, water attenuation masses (94,149,155) (Fig. 10.43). They do not enhance following contrast administration.
Figure 10.42. Pancreatic sarcoma in a 17-year-old boy with gastrointestinal bleeding. A large, hypoattenuating soft tissue mass (arrows) arises from the pancreatic head.
Acquired cystic lesions include pseudocysts, cysts of parasitic origin, and retention cysts related to cystic fibrosis (see above). Multiple cysts may be seen in systemic diseases and syndromes, including von Hippel–Lindau disease, Beckwith–Wiedemann syndrome, autosomal dominant polycystic disease, and Meckel–Gruber syndrome (149).
Von Hippel–Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome caused by a mutation of a tumor suppressor gene, the VHL gene. VHL is associated with various neoplasms, most commonly retinal, cerebellar, and spinal hemangioblastoma; renal cell carcinoma; pheochromocytoma; and pancreatic tumors (microcystic adenomas, adenocarcinoma, and islet cell tumors). Cysts in the pancreas, kidney, liver, epididymis, and adrenal glands are also common (157,158). Most pancreatic cysts are clinically silent and discovered during routine screening examinations; rarely epigastric pain, diabetes mellitus, or steatorrhea have been reported in patients with extensive cystic disease. On CT, they have near-water-attenuation contents and thin or imperceptible walls (Fig. 10.44).
Figure 10.43. Congenital pancreatic cyst in a term newborn girl diagnosed with a large abdominal cyst on antenatal sonography. Contrast-enhanced CT shows the large water-attenuation cyst (asterisk) and also multiple dilated biliary ducts (arrows). (Reprinted from
Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006;26:1211–1238, with permission.
)
Figure 10.44. Pancreatic cysts in a 2-year-old girl with von Hippel–Lindau disease and abdominal pain. Pancreatic parenchymal phase CT shows several small water-density cysts (arrows) with imperceptible walls in the tail of the pancreas.
Lymph Nodes
CT Technique
As in other parts of the body, the demonstration of small retroperitoneal lymph nodes or masses requires meticulous attention to technique. Both oral and intravenous contrast agents are usually needed to distinguish between normal structures (e.g., bowel and vessels) and lymph nodes. Scanning should be initiated during the portal venous phase of contrast enhancement.
Normal Anatomy
Normal retroperitoneal lymph nodes are not routinely seen on CT examinations of infants and young children, owing to the small size of these nodes and the inherent paucity of retroperitoneal fat. Any node, regardless of size, in prepubertal patients should be regarded as abnormal. On the other hand, one or two small nodes may be seen in adolescent patients, appearing as round or oval soft tissue structures not exceeding 10 mm in size (1,159). Multiple nodes or nodes in the retrocrural area and pelvis should be viewed with suspicion, especially if there is a history of malignancy. Normal lymph nodes usually show little enhancement after administration of intravenous contrast agent. The attenuation of normal lymph nodes on unenhanced and contrast-enhanced CT scans is equal to that of muscle. Retroperitoneal lymph nodes usually have a perivascular distribution, surrounding the aorta and inferior vena cava.
P.349

Lymphadenopathy
The CT appearance of lymphadenopathy ranges from one or more enlarged individual lymph nodes to a large, soft tissue mass in which discrete nodes are no longer recognizable (160) (Fig. 10.45). A large mantle of confluent adenopathy may obscure the contours of adjacent structures and displace the great vessels and bowel anteriorly as well as the kidneys laterally. Both benign and malignant lymphadenopathy may show enhancement following administration of intravenous contrast material. The pattern of enhancement may be homogeneous, heterogeneous, central, or peripheral.
False-positive diagnoses of lymphadenopathy result either from misinterpretation of nodal enlargement owing to benign disease as malignancy or from mistaking unopacified collapsed bowel loops or normal vascular structures as nodal enlargement, a problem that is easily addressed by meticulous attention to technique. False-negative interpretations are almost always due to the inability to recognize replaced architecture in normal-sized nodes (161,162).
In some cases, the attenuation value of the enlarged nodes is helpful in suggesting a diagnosis (160). High-attenuation nodes may be seen when there is excess iron deposition, usually secondary to multiple transfusions for chronic anemia. Calcified nodes can be seen in old healed granulomatous infections, neuroblastoma (Fig. 10.46), and untreated or treated lymphoma. Low-attenuation (+10 to +30 HU) lymph nodes can be associated with testicular neoplasms, particularly teratocarcinoma (Fig. 10.47), lymphoma, Mycobacterium infection (usually M. tuberculosis) (163,164), and histoplasmosis. The relatively low attenuation may be the result of liquefaction, necrosis, or the deposition of fat or fatty acids in the lymph nodes.
Figure 10.45. Retroperitoneal lymphadenopathy due to lymphoma. A, B: Two contrast-enhanced CT scans show enlarged retroperitoneal lymph nodes (N) that maintain their discrete contours. The aorta (A) and inferior vena cava are displaced anteriorly. C: CT scan in another patient shows a homogeneous soft tissue mass (arrows), representing coalesced lymph nodes displacing of the aorta (A) and inferior vena cava (C) anteriorly.
Lymphoma, Wilms tumor, and neuroblastoma are the common causes of malignant retroperitoneal lymphadenopathy in children, but other neoplasms, such as pelvic rhabdomyosarcoma and ovarian and testicular malignancies, also can involve these nodes. In the latter two conditions, tumor usually first spreads to the retroperitoneal nodes before involving the pelvic nodes.
Lymphoma
Lymphoma is a common cause of retroperitoneal lymphadenopathy. It is the third most common malignancy of
P.350

childhood after leukemia and the central nervous system tumors, and Hodgkin disease is slightly more common than non-Hodgkin lymphoma (165,166). Lymphomatous nodes have a fairly homogeneous appearance on CT with attenuation similar to that of paraspinal muscle (Fig, 10.45). Rarely, lower-attenuation values are seen. Lymphomatous nodes may calcify following therapy; less commonly, calcifications are seen in untreated disease.
Figure 10.46. Calcified lymphadenopathy in neuroblastoma. Contrast-enhanced CT scan through the level of the kidneys demonstrates a right paravertebral neuroblastoma (NB) and enlarged calcified retroperitoneal lymphadenopathy (arrows).
In most patients who receive adequate therapy, the CT scan returns to normal. However, massive lymphadenopathy may not regress completely, even when patients are in complete clinical remission, leaving a residual, although smaller, soft tissue mass. Fibrotic changes cannot be distinguished reliably from viable lymphoma by CT, as the attenuation of both is identical. Serial CT examinations demonstrating stability of the mass often suffice to determine the adequacy of treatment.
MRI and positron emission tomography CT with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) are useful ad-juncts to CT to assess treatment response in a patient who has a residual mass (167,168,169). Low signal intensity on T1- and T2-weighed or fat-suppressed MR sequences is typical of mature fibrotic tissue, whereas high signal intensity on T2-weighted or fat-suppressed images is more suggestive of viable neoplasm. However, increased signal intensity is not specific for active tumor, and it also may be seen with infection, hemorrhage, necrosis, and immature fibrotic tissue in the early posttreatment course. On FDG-PET imaging, increased activity in a mass suggests residual tumor, whereas absent activity suggests fibrosis.
Figure 10.47. Low-attenuation adenopathy in a 15-year-old boy with testicular teratocarcinoma. Contrast-enhanced CT scan demonstrates heterogeneous, low-attenuation adenopathy (arrows) in the left renal hilum.
Testicular Neoplasms
Testicular tumors account for about 2% of all childhood malignancies and for 2% to 3% of solid malignant neoplasms (170,171). In prepubertal boys, between 70% and 90% of testicular neoplasms are of germ cell origin (usually yolk sac carcinomas and benign teratomas), and 10% to 30% are non–germ cell tumors (Leydig or Sertoli cell tumors). In pubertal boys, testicular tumors are more likely to be embryonal carcinomas, seminomas, choriocarcinomas, and teratocarcinomas.
Testicular tumors spread via the lymphatic system. The testicular lymphatics follow the course of the testicular arteries and veins and drain initially into lymph nodes in or near the renal hilus (Fig. 10.47). After involvement of these nodes, the tumor may spread to para-aortic nodes and then to pelvic, mediastinal, and supraclavicular nodes. Hematogenous dissemination also may occur to the lungs, liver, and brain.
Residual retroperitoneal masses may remain on CT even after successful treatment of metastatic disease. Such masses may represent posttreatment fibrosis or a mature teratoma (172,173). As discussed above, serial CT imaging, MRI, and PET/CT imaging may play a role in differentiating between fibrosis and tumor.
Retroperitoneal Soft Tissues
Primary retroperitoneal tumors can arise from mesenchymal tissue (e.g., fat, muscle, vessels, lymphatics, and connective tissues), neurogenic tissue (nerve, sympathetic ganglia), or embryonic remnants (174). The benign
P.351

primary tumors in children include mature and immature teratoma (175,176), hemangioendothelioma and hemangioma, lymphangioma (177,178), lipoblastoma, inflammatory myofibroblastic tumor (179), and tumors of neural origin (180,181,182,183). Symptoms are usually related to compression of adjacent structures and include abdominal or back pain caused by pressure on nerve roots, nausea or vomiting caused by bowel compression, and lower extremity swelling caused by venous compression.
Figure 10.48. Retroperitoneal rhabdomyosarcoma in a 5-year-old girl. Axial (A) and coronal (B) reformatted CT scans show a homogeneous retroperitoneal mass (M) with irregular borders displacing the right kidney laterally and the aorta (arrow) anteriorly. There is a small amount of ascites (A).
Figure 10.49. Retroperitoneal teratoma. A: A 4-month-old girl with a palpable abdominal mass. Contrast-enhanced CT scans show a well-circumscribed, predominantly fluid-filled mass containing areas of fat (F) and calcifications (arrow). Histologic sections showed the presence of fat, bone, cartilage, and neural elements. B: CT scan of a 2-year-old boy shows a right paravertebral mass (arrows) with soft tissue and fatty elements. Histologic sections showed the presence of hair and fat.
The common malignant retroperitoneal tumors are neuroblastoma and rhabdomyosarcoma. Less common tumors are fibrosarcoma (184), malignant germ cell
P.352

tumor, leiomyosarcoma, malignant fibrous histiocytoma, and Ewing sarcoma. Most malignant tumors appear on CT as bulky, soft tissue masses with irregular margins and attenuation values slightly less than or equal to that of muscle (Fig. 10.48). Often, they have a heterogeneous matrix, which may help to differentiate them from lymphoma, as lymphomas are typically homogeneous. Vessel displacement or encasement, ascites, invasion of adjacent organs, and hepatic metastases also may be seen.
Some benign tumors have unique CT findings that suggest a specific histologic diagnosis. Benign teratoma typically appears as a well-defined complex mass containing varying amounts of fluid, fat, soft tissue, and bone or calcifications (Fig. 10.49) (175,176). Hemangioendothelioma and hemangioma are hypervascular and appear as an enhancing soft tissue mass (Fig. 10.50). Calcification is common. Lymphangioma is typically seen as a well-circumscribed, unilocular or septated, near-water-attenuation mass (Fig. 10.51) (177,178). Lymphangiomas can present with hemorrhage, however, and simulate a solid tumor mass or abscess on CT scans. Lipoblastoma contains multiple lobules of immature fatty tissue separated by fibrous septa. On CT, it appears as a well-circumscribed or poorly marginated mass that contains an admixture of fat- and soft tissue–density elements, depending on the relative amount of lipomatous and fibrous tissue (Fig. 10.52). Lipoblastoma and liposarcoma are indistinguishable on imaging studies, but the latter tumor is exceedingly rare in children.
Benign retroperitoneal neurogenic tumors can arise from ganglion cells (neuroblastoma, ganglioneuroblastoma, ganglioneuroma), from the paraganglionic system (pheochromocytoma, paraganglioma), or from nerve sheath cells (neurofibroma, schwannoma).
Figure 10.50. Retroperitoneal hemangioendothelioma. An enhancing soft tissue mass (arrows) is noted in the left paravertebral area. The tumor displaces the aorta (A) and inferior vena cava (C) anteriorly.
Figure 10.51. Retroperitoneal lymphangioma. A near-water attenuation mass (M) occupies the left renal hilum, encasing the renal artery (arrow) and displacing the renal vein (arrowhead) anteriorly.
At CT, neurogenic tumors appear as well-defined smooth or lobulated masses (Figs. 10.53 and 10.54). They may be round or elongated, the latter appearance resulting when the tumor follows the course of the nerve. Calcification is common in the ganglion cell tumors. Most lesions are homogeneous with attenuation similar to that of muscle. However, low-attenuation areas may be noted because of high lipid or water content, entrapment of perineural
P.353

adipose tissue, or areas of necrosis or cystic degeneration (Fig. 10.53B). Malignant and benign tumors can look identical, but irregular infiltrative borders and internal heterogeneity and/or metastases should raise the suspicion of malignancy (Fig. 10.55). Distinguishing between neurofibroma and other neural tumors requires tissue sampling.
Figure 10.52. Lipoblastoma. Contrast-enhanced CT shows a well-circumscribed retroperitoneal mass (arrows), predominantly of fat attenuation, displacing the right kidney anteriorly. The right kidney is hydronephrotic. C, dilated renal calyces. (Case courtesy of the Armed Forces Institute of Pathology.)
Figure 10.53. Neurofibromatosis. A: Contrast-enhanced CT demonstrates a lobulated, homogeneous mass (M) anterior and lateral to the left psoas muscle. The attenuation of the lesion is similar to muscle. Smaller neurofibromas are seen in the subcutaneous soft tissues. B: Contrast-enhanced CT in another patient demonstrates bilateral low-attenuation masses (arrows) extending along the course of the lumbar nerves and displacing the psoas muscles anteriorly. The attenuation and location are typical for a neurogenic tumor.
Retroperitoneal Hemorrhage
Retroperitoneal hemorrhage in children usually follows blunt abdominal trauma. Less frequently, it is a complication of percutaneous renal biopsy, surgery, anticoagulant therapy, a bleeding diathesis, malpositioned indwelling catheter, or retroperitoneal malignancy. The location and attenuation characteristics of the blood vary with the source and duration of the hemorrhage. Hemorrhage resulting from renal trauma or biopsy typically surrounds the kidney before extending into the retroperitoneum. Hemorrhage associated with anticoagulant therapy or a bleeding diathesis may initially diffusely infiltrate the retroperitoneum.
On enhanced CT, acute and subacute hemorrhage usually have an attenuation value equal to or less than that of muscle (185). Over time, the attenuation value decreases, usually in a centripetal fashion. A chronic hematoma appears as a well-circumscribed, low-attenuation mass (+20 to +40 HU) with a higher attenuation rim (186). The rim may later calcify. Hemorrhage may be localized or diffusely infiltrate the retroperitoneum (Fig. 10.56). Contrast-enhanced CT may show active arterial extravasation, appearing as a focal high-attenuation area surrounded by a large hematoma (185). On noncontrast CT, acute hemorrhage may appear denser than muscle.
Retroperitoneal Fibrosis
Retroperitoneal fibrosis is uncommon in children (187,188,189). It is usually idiopathic, although it may be associated with some medications (methysergide) and
P.354

systemic diseases, including systemic lupus erythematosus, juvenile idiopathic arthritis, ankylosing spondylitis, malignancy, infection, and sickle cell disease (190). Retroperitoneal hemorrhage and urine leakage may also cause fibrosis (188). The fibrotic process typically begins at or below the aortic bifurcation and then extends cephalad along the anterior surface of the spine, encasing the blood vessels and ureters, or caudad into the pelvis, compressing the rectosigmoid colon and bladder (187). At CT, retroperitoneal fibrosis appears as a well-marginated soft tissue mass, often encasing the aorta and inferior vena cava. Loss of the normal fat planes surrounding these structures is common. There may be hydronephrosis or ureteral narrowing (191). Retroperitoneal fibrosis causes slight or no anterior displacement of the aorta; marked displacement is atypical and should suggest the possibility of a primary retroperitoneal tumor (187). Variable contrast enhancement is seen. Early-stage disease may show moderate to marked enhancement, whereas late-stage disease may be hypoattenuating.
Figure 10.54. Retroperitoneal schwannoma. Contrast-enhanced CT scan shows a minimally heterogeneous right paravertebral mass (M) with attenuation similar to muscle. This appearance is nonspecific and can mimic any other neural tumor.
Figure 10.55. Neurofibrosarcoma in a patient with neurofibromatosis. Contrast-enhanced CT scan demonstrates a heterogeneous, low-attenuation paraspinal mass with irregular borders. A pleural metastasis (arrow) supports the diagnosis of a malignant neurogenic tumor. Multiple pulmonary metastases were seen on lung window settings.
Figure 10.56. Acute retroperitoneal hemorrhage. A: A 14-year-old girl receiving heparin therapy for deep venous thrombosis and pulmonary emboli. Contrast-enhanced CT scan shows soft tissue–attenuation hematoma tracking into the pararenal space (black arrows), lateral conal fascia (white arrows), and psoas muscle (P). The left kidney (K) is displaced laterally indicating the retroperitoneal location of the blood. B: A 6-year-old boy in a motor vehicle accident 2 hours earlier. Contrast-enhanced CT scan shows low attenuation blood in the right pararenal space (white arrows) and a focal high-density area (black arrow) representing active arterial extravasation.
Psoas Muscle
Normal Anatomy
The paired psoas muscles descend in a paravertebral location from the transverse processes of the 12th thoracic vertebra into the iliac fossa, where they merge with the iliacus to become the iliopsoas muscle. At CT, the psoas major muscles appear as paired soft tissue–attenuation, paraspinal structures. The cranial ends of the muscles have a triangular shape, whereas the caudal ends are
P.355

ovoid or round. The size of the muscles increases as they descend into the pelvis (192).
Figure 10.57. Psoas abscess. Contrast-enhanced axial (A) and coronal (B) reformatted CT scans show a low-attenuation fluid collection with an enhancing rim in the right iliopsoas muscle (arrows).
The psoas minor muscles are located immediately anterior to the psoas major muscles. At CT, they may be seen as small, rounded, soft tissue structures anterior to the psoas major muscles. These slender muscles should not be mistaken for adenopathy.
The psoas muscles are closely apposed to the posterior aspect of the retroperitoneum and its contents, including lymph nodes, kidneys, pancreas, duodenum, and the ascending and descending colon. Disease processes that involve the retroperitoneum and vertebral bodies can also involve the psoas muscles.
Psoas Abscess
Psoas abscess is usually the result of direct extension of contiguous infection, such as appendicitis, inflammatory bowel disease, renal infection, or vertebral osteomyelitis. Less commonly, there is no known source and the abscess is presumed to be of hematogenous origin (192,193). The classic presentation is that of fever, back pain, and a limp. CT findings are an enlarged psoas muscle containing a focal low-attenuation fluid collection (194) (Fig 10.57). Enhancement of the abscess wall or surrounding soft tissues may be seen after administration of intravenous contrast material. The demonstration of gas bubbles within the psoas muscle is diagnostic of infection, but this finding is uncommon. Necrotic tumors and hematomas can mimic the CT appearance of psoas abscess. When imaging findings are nonspecific, CT can be used to guide percutaneous needle aspiration or biopsy for diagnosis (192,194).
Neoplasm
The common neoplastic diseases involving the psoas muscles are lymphoma, Wilms tumor, and Ewing sarcoma. Like infection, tumor within the psoas muscle is more often the result of direct extension rather than intrinsic disease. At CT, psoas tumors usually appear as heterogeneous soft tissue masses with well-circumscribed or poorly defined margins. The involved muscle is enlarged (Fig. 10.58).
Hemorrhage
Hemorrhage into the psoas muscle usually is the result of trauma (Fig. 10.56A) or a coagulopathy, such as hemophilia, or anticoagulant therapy. As mentioned earlier, the attenuation of the hemorrhage depends on the age of the blood products (see discussion of retroperitoneal hemorrhage). The CT appearance of subacute or chronic hemorrhage can mimic that of neoplasm and abscess. In cases in which the findings are nonspecific, CT can be used to
P.356

guide percutaneous aspiration for culture and histologic examination.
Figure 10.58. Rhabdomyosarcoma of the psoas muscle. Contrast-enhanced CT shows enlargement of the right psoas muscle by a heterogeneous mass containing cystic changes (arrows).
Fatty Replacement
The psoas muscle may atrophy as a result of neuromuscular disorders. The characteristic CT features are small size and low attenuation due to fatty replacement.
References
1. Siegel MJ. Pediatric applications of computed body tomography. In: Lee JKT, Sagel SS, Stanley RJ, et al., eds. Computed Body Tomography with MRI Correlation. Philadelphia: Lippincott Williams & Wilkins; 2006:1727–1791.
2. Siegel MJ. Pediatric abdominal applications. In: Fishman EK, Jeffrey RB Jr, eds. Multidetector CT: Principles, Techniques and Clinical Applications. Philadelphia: Lippincott Williams & Wilkins; 2004:511–531.
3. Korobkin M, Silverman PM, Quint LE, et al. CT of the extraperitoneal space: normal anatomy and fluid collections. AJR Am J Roentgenol 1992;159:933–942.
4. Frush DP, Donnelly LF, Bissett GS. Effect of scan delay on hepatic enhancement for pediatric abdominal multislice helical CT. AJR Am J Roentgenol 2001;176:1559–1561.
5. Paterson A. Adrenal pathology in childhood: a spectrum of disease. Eur Radiol 2002;12:2491–2508.
6. Westra SJ, Zaninovic AC, Hall TR, et al. Imaging of the adrenal gland in children. Radiographics 1994;14:1323–1340.
7. O'Hara SM, Donnelly LF. Intense contrast enhancement of the adrenal glands: another abdominal CT finding associated with hypoperfusion complex in children. AJR Am J Roentgenol 1999;173:995–997.
8. Barwick TD, Malhotra A, Webb JA, et al. Embryology of the adrenal glands and its relevance to diagnostic imaging. Clin Radiol 2005;60:953–959.
9. Scott EM, Thomas A, McGarrigle HH, et al. Serial adrenal ultrasonography in normal neonates. J Ultrasound Med 1990;9:279–283.
10. Siegel MJ. Adrenal glands, pancreas and other retroperitoneal structures. In: Siegel MJ, ed. Pediatric Sonography. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002:475–527.
11. Kenney PJ, Robbins GL, Ellis DA, et al. Adrenal glands in patients with congenital renal anomalies: CT appearance. Radiology 1985;155:181–182.
12. Strouse PJ, Haller JO, Berdon WE, et al. Horseshoe adrenal gland in association with asplenia: presentation of six new cases and review of the literature. Pediatr Radiol 2002;32: 778–782.
13. Dunnick NR. Hanson lecture. Adrenal imaging: current status. AJR Am I Roentgenol 1990;154:927–936.
14. Heller RE, Fernbach SK. Two apparent suprarenal masses. Two cases in children: heterotaxy syndrome with spleen lying in suprarenal space and gastric duplication cyst lying in suprarenal space. Pediatr Radiol 2000;30:400–403.
15. Abramson SJ. Adrenal neoplasms in children. Radiol Clin North Am 1997;35:1415–1453.
16. Brodeur GM, Maris JM. Neuroblastoma. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2001:895–933.
17. Lonergan GJ, Schwab CM, Suarez ES, et al. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 2002;22:911–934.
18. McHugh K. Renal and adrenal tumours in children. Cancer Imaging 2007;7:41–51
19. Papaioannou G, McHugh K. Neuroblastoma in childhood: review and radiological findings. Cancer Imaging 2005;5: 116–127.
20. Brodeur GB, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins; 2006: 933–970.
21. Parisi MT, Hattner RS, Matthay KK, et al. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus. J Nucl Med 1993;34:1922–1926.
22. Wong A. An update on opsoclonus. Curr Opin Neurol 2007; 20:25–31.
23. Davies RP, Slavotinek JP, Dorney SF. VIP secreting tumours in infancy. A review of radiological appearances. Pediatr Radiol 1990;20:504–508.
24. Brodeur G M, Pritchard J, Berthold F, et al. Revision of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993;11:1466–1477.
25. Berthold F, Trechow R, Utsch S, et al. Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992;4:207–215.
26. Kushner BH. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med 2004;45:1172–1188.
27. Siegel MJ, Ishwaran H, Fletcher BD, et al. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology 2002;223:168–175.
28. Goo HW, Choi SH, Ghim T, et al. Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 2005;35: 766–773.
29. Laffan EE, O'Connor R, Ryan SP, et al. Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging. Pediatr Radiol 2004;34:472-480.
30. Mazumdar A, Siegel MJ, Narra V, et al. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR Am J Roentgenol 2002;179:1261–1266.
31. Cassady C, Winters WD. Bilateral cystic neuroblastoma: imaging features and differential diagnoses. Pediatr Radiol 1997;27:758–759.
32. Richards ML, Gundersen AE, Williams MS. Cystic neuroblastoma of infancy. J Pediatr Surg 1995;30:1354–1357.
33. Teoh SK, Whitman GJ, Chew FS. Neonatal neuroblastoma. AJR Am J Roentgenol 1997;168:54.
34. Fernbach SK. Ascites produced by peritoneal seeding of neuroblastoma. Pediatr Radiol 1993;23:569.
35. Day DL, Johnson R, Cohen MD. Abdominal neuroblastoma with inferior vena caval tumor thrombus: report of three cases (one with right atrial extension). Pediatr Radiol 1991; 21:205–207.
36. Goldman S, Philip J. The adrenal glands. In: Lee JKT, Sagel SS, Stanley RJ, et al., eds. Computed Body Tomography with MRI Correlation. Philadelphia: Lippincott Williams & Wilkins; 2006:1311–1374.
37. Reddy VS, O'Neill JA Jr. Holcomb GW 3rd, et al. Twenty-five-year surgical experience with pheochromocytoma in children. Am Surg 2000;66:1085–1091; discussion 1092.
38. Farrelly CA, Daneman A, Martin DJ, et al. Pheochromocytoma in childhood: the important role of computed tomography in tumour localization. Pediatr Radiol 1984;14:210–214.
39. Hayes WS, Davidson AJ, Grimley PM, et al. Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings. AJR Am J Roentgenol 1990;155:1247–1250.
40. Bessell-Browne R, O'Malley ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with IV administration of nonionic contrast material. AJR Am J Roentgenol 2007;188:970–974.
41. Argons GA. Lonergan GJ, Dickey GE, et al. Adrenocortical neoplasms in children: radiologic-pathologic correlation. Radiographics 1999;19:9898–1008.
42. Lack EE. Adrenal cortical neoplasms in childhood. In: Lack EE, ed. Atlas of Tumor Pathology: Tumors of the Adrenal Gland and Extra Adrenal Paraganglia, fasc 19, ser 3. Washington, DC: Armed Forces Institute of Pathology; 1997:153–168.
43. Ribeiro J, Ribeiro RC, Fletcher BD. Imaging findings in pediatric adrenocortical carcinoma. Pediatr Radiol 2000;30:45–51.
P.357

44. Daneman A, Chan HS, Martin J. Adrenal carcinoma and adenoma in children: a review of 17 patients. Pediatr Radiol 1983;13:11–18.
45. Chiche L, Dousset B, Kieffer E, et al. Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 2006;139:15–27.
46. Godine LB, Berdon WE, Brasch RC, et al. Adrenocortical carcinoma with extension into inferior vena cava and right atrium: report of 3 cases in children. Pediatr Radiol 1990; 20:166–168; discussion 169.
47. Kreissig R, Amthauer H, Krude H, et al. The use of FDG-PET and CT for the staging of adrenocortical carcinoma in children. Pediatr Radiol 2000;30:306.
48. Rockall AG, Babar SA, Sohaib SA, et al. CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome. Radiographics 2004;24:435–452.
49. Doppman JL, Travis WD, Nieman L, et al. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 1989; 172:415–420.
50. Doppman JL, Gill JR Jr, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 1992;184:677–682.
51. Dunnick NR, Leight GS Jr, Roubidoux MA, et al. CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. AJR Am J Roentgenol 1993;160:321–324.
52. Radin DR, Manoogian C, Nadler JL. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies. AJR Am J Roentgenol 1992; 158:553–557.
53. Drucker S, New MI. Disorders of adrenal steroidogenesis. Pediatr Clin North Am 1987;34:1055–1066.
54. Esser T, Chaoui R. Enlarged adrenal glands as a prenatal marker of congenital adrenal hyperplasia: a report of two cases. Ultrasound Obstet Gynecol 2004;23:293–297.
55. Fitoz S, Atasoy C, Adiyaman P, et al. Testicular adrenal rests in a patient with congenital adrenal hyperplasia: US and MRI features. Comput Med Imaging Graph 2006;30:465–468.
56. Calhoun SK, Murphy RC, Shariati N, et al. Extramedullary hematopoiesis in a child with hereditary spherocytosis: an uncommon cause of an adrenal mass. Pediatr Radiol 2001; 31:879–881.
57. Cobanoglu U, Yaris N, Cay A. Adrenal myelolipoma in a child. Pediatr Surg Int 2005;21:500–502.
58. Soboleski D, Mehta S, Kamal I, et al. Hemangioendothelioma of the adrenal gland in a 4-month-old male infant. AJR Am J Roentgenol 1999;172:235–237.
59. Pinto A, Scaglione M, Guidi G, et al. Role of multidetector row computed tomography in the assessment of adrenal gland injuries. Eur J Radiol 2006;59:355–358.
60. Nimkin K, Teeger S, Wallach MT, et al. Adrenal hemorrhage in abused children: imaging and postmortem findings. AJR Am J Roentgenol 1994;162:661–663.
61. Sivit CJ, Ingram JD, Taylor GA, et al. Posttraumatic adrenal hemorrhage in children: CT findings in 34 patients. AJR Am J Roentgenol 1992;158:1299–1302.
62. Bowen AD, Keslar PJ, Newman B, et al. Adrenal hemorrhage after liver transplantation. Radiology 1990;176:85–88.
63. Wang LJ, Wong YC, Chen CJ, et al. Imaging spectrum of adrenal pseudocysts on CT. Eur Radiol 2003;13:531–535.
64. McCauley RG, Beckwith JB, Elias ER, et al. Benign hemorrhagic adrenocortical macrocysts in Beckwith-Wiedemann syndrome. AJR Am J Roentgenol 1991;157:549–552.
65. Ozmen MN, Aygun N, Kilic I, et al. Wolman's disease: ultrasonographic and computed tomographic findings. Pediatr Radiol 1992;22:541–542.
66. Polo JL, Villarejo PJ, Molina M, et al. Giant mature cystic teratoma of the adrenal region. AJR Am J Roentgenol 2004; 183:837–838.
67. Herman TE, Siegel MJ. CT of the pancreas in children. AJR Am J Roentgenol 1991;157:375–379.
68. Nijs E, Callahan MJ, Taylor GA. Disorders of the pediatric pancreas: imaging features. Pediatr Radiol 2005;35:358–373.
69. Vaughn DD, Jabra AA, Fishman EK. Pancreatic disease in children and young adults: evaluation with CT. Radiographics 1998;18:1171–1187.
70. Hollett MD, Jorgensen MJ, Jeffrey RB Jr. Quantitative evaluation of pancreatic enhancement during dual-phase helical CT. Radiology 1995;195:359–361.
71. Morgan DE, Stanley RJ. Pancreas. In: Lee JKT, Sagel SS, Stanley RJ, et al., eds. Computed Body Tomography with MRI Correlation. Philadelphia: Lippincott Williams & Wilkins; 2006:1007–1100.
72. Siegel MJ, Martin KW, Worthington JL. Normal and abnormal pancreas in children: US studies. Radiology 1987; 165:15–18.
73. Schulte SJ. Embryology, normal variation, and congenital anomalies of the pancreas. In: Freeny PC, Stevenson GW, eds. Alimentary Tract Radiology. St. Louis, MO: Mosby; 1994:1039–1051.
74. Yu J, Turner MA, Fulcher AS, et al. Congenital anomalies and normal variants of the pancreaticobiliary tract and the pancreas in adults: part 2: pancreatic duct and pancreas. AJR Am J Roentgenol 2006;187:1544–1553.
75. Jackson WD. Pancreatitis: etiology, diagnosis, and management. Curr Opin Pediatr 2001;13:447–451.
76. Neblett WW 3rd, O'Neill JA Jr. Surgical management of recurrent pancreatitis in children with pancreas divisum. Ann Surg 2000;231:899–908.
77. Soto JA, Lucey BC, Stuhlfaut JW. Pancreas divisum: depiction with multi-detector CT. Radiology 2005;235:503–508.
78. Ahmed A, Chan KF, Song IS. Annular pancreas. J Comput Assist Tomogr 1982;6:409–411.
79. Ueki T, Yao T, Beppu T, et al. Three-dimensional computed tomography pancreatography of an annular pancreas with special reference to embryogenesis. Pancreas 2006;32: 426–429.
80. Shah K, DeRidder P, Schwab R, et al. CT diagnosis of dorsal pancreas agenesis. J Comput Assist Tomogr 1987;11:170–171.
81. Herman TE, Siegel MJ. Polysplenia syndrome with congenital short pancreas. AJR Am J Roentgenol 1991;156:799–800.
82. Fulcher AS, Turner MA. Abdominal manifestations of situs anomalies in adults. Radiographics 2002;22:1439–1456.
83. Wildling R, Schnedl WJ, Reisinger EC, et al. Agenesis of the dorsal pancreas in a woman with diabetes mellitus and in both of her sons. Gastroenterology 1993;104:1182–1186.
84. Coral A, Jones SN, Lees WR. Dorsal pancreas presenting as a mass in the chest. AJR Am J Roentgenol 1987;149:718–720.
85. Eklof O, Lassrich A, Stanley P, et al. Ectopic pancreas. Pediatr Radiol 1973;1:24–27.
86. Chou SJ, Chou YW, Jan HC, et al. Ectopic pancreas in the ampulla of Vater with obstructive jaundice. A case report and review of literature. Dig Surg 2006;23:262–264.
87. Berrocal T, Pajares MP, Zubillaga AF. Pancreatic cystosis in children and young adults with cystic fibrosis: sonographic, CT, and MRI findings. AJR Am J Roentgenol 2005;184: 1305–1309.
88. Carucci LR, Jacobs JE. Focal fatty sparing of the pancreatic head in cystic fibrosis: CT findings. Abdom Imaging 2003;28: 853–855.
89. Sodhi KS, Thapa BR, Khandelwal S, et al. Pancreatic lipomatosis in an infant with cystic fibrosis. Pediatr Radiol 2005;35:1157–1158.
90. Hernanz-Schulman M, Teele RL, Perez-Atayde A, et al. Pancreatic cystosis in cystic fibrosis. Radiology 1986;158: 629–631.
91. Cubuk M, Arslan G, Ceken K, et al. Schwachman-Diamond syndrome. A case report. Acta Radiol 2000;41:627–628.
92. Trellis DR, Clouse RE. Johanson-Blizzard syndrome. Progression of pancreatic involvement in adulthood. Dig Dis Sci 1991;36:365–369.
93. Raeder H, Haldorsen IS, Ersland L, et al. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes 2007;56:444–449.
P.358

94. Chung EM, Travis MD, Conran RM. Pancreatic tumors in children: radiologic-pathologic correlation. Radiographics 2006;26:1211–1238.
95. Sempoux C, Guiot Y, Jaubert F, et al. Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocr Pathol 2004;15:241–246.
96. Hardy OT, Hernandez-Pampaloni M, Saffer JR, et al. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr 2007;150:140–145.
97. Berrocal T, Luque AA, Pinilla I, et al. Pancreatic regeneration after near-total pancreatectomy in children with nesidioblastosis. Pediatr Radiol 2005;35:1066–1070.
98. Stringer MD. Pancreatitis and pancreatic trauma. Semin Pediatr Surg 2005;14:239–246.
99. Kawahara H, Takahashi T, Okada A. Characteristics of duodenal duplications causing pancreatitis in children and adolescents: a case report and review of the literature. J Pediatr Gastroenterol Nutr 2002;35:372–376.
100. Bradley EL III. A clinically based classification system for acute pancreatitis. Arch Surg 1993;128:586–590.
101. Balthazar EJ, Freeny PC, vanSonnenberg E. Imaging and intervention in acute pancreatitis. Radiology 1994;193: 297–306.
102. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331–336.
103. King LR, Siegel MJ, Balfe DM. Acute pancreatitis in children: CT findings of intra- and extrapancreatic fluid collections. Radiology 1995;195:196–200.
104. Koizumi M, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: diagnostic criteria for acute pancreatitis. J Hepatobiliary Pancreat Surg 2006; 13:25–32.
105. McCowin MJ, Federle MP. Computed tomography of pancreatic pseudocysts of the duodenum. AJR Am J Roentgenol 1985;145:1003–1007.
106. Jaffe RB, Arata JA Jr, Matlak ME. Percutaneous drainage of traumatic pancreatic pseudocysts in children. AJR Am J Roentgenol 1989;152:591–595.
107. Freeny PC, Lewis GP, Traverso LW, et al. Infected pancreatic fluid collections: percutaneous catheter drainage. Radiology 1988;167:435–441.
108. Ahmed H, Hagspiel H, McGahren E, et al, et al. Pancreatic pseudoaneurysm in a child with hereditary pancreatitis: diagnosis with multidetector CT angiography. Pediatr Radiol 2004;34:656–659.
109. Hyare H, Desigan S, Nicholl H, et al. Multi-section CT angiography compared with digital subtraction angiography in diagnosing major arterial hemorrhage in inflammatory pancreatic disease. Eur J Radiol 2006;59:295–300.
110. Rothstein FC, Wyllie R, Gauderer MW. Hereditary pancreatitis and recurrent abdominal pain of childhood. J Pediatr Surg 1985;20:535–537.
111. Atkinson GO Jr, Wyly JB, Gay BB Jr, et al. Idiopathic fibrosing pancreatitis: a cause of obstructive jaundice in childhood. Pediatr Radiol 1988;18:28–31.
112. Deshpande AV, LaHei ER, Shun A, et al. Idiopathic fibrosing pancreatitis in children—a single-center experience. J Pediatr Surg 2006;41:1987–1991.
113. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology 2004;233:345–352.
114. Jaffe R. The pancreas. In: Stocker J, Dehner L, eds. Pediatric Pathology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002:797–834.
115. Jaksic T, Yaman M, Thorner P, et al. A 20-year review of pediatric pancreatic tumors. J Pediatr Surg 1992;27:1315–1317.
116. Shorter NA, Glick RD, Klimstra DS, et al. Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg 2002;37:887–892.
117. Vane DW, Grosfeld JL, West KW, et al. Pancreatic disorders in infancy and childhood: experience with 92 cases. J Pediatr Surg 1989;24:771–776.
118. Muguerza R, Rodriguez A, Formigo E, et al. Pancreatoblastoma associated with incomplete Beckwith-Wiedemann syndrome: case report and review of the literature. J Pediatr Surg 2005;40:1341–1344.
119. Klimstra DS, Wenig BM, Adair CF, et al. Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol 1995;19:1371–1389.
120. Solcia E, Capella C, Klöppel G. Atlas of Tumor Pathology: Tumors of the Pancreas. Washington, DC: Armed Forces Institute of Pathology; 1997.
121. Ferrozzi F, Zuccoli G, Bova D, et al. Mesenchymal tumors of the pancreas: CT findings. J Comput Assist Tomogr 2000;24: 622–627.
122. Gupta AK, Mitra DK, Berry M, et al. Sonography and CT of pancreatoblastoma in children. AJR Am J Roentgenol 2000;174:1639–1641.
123. Lee JY, Kim IO, Kim WS, et al. CT and US findings of pancreatoblastoma. J Comput Assist Tomogr 1996;20: 370–374.
124. Lumkin B, Anderson MW, Ablin DS, et al. CT, MRI, and color Doppler ultrasound correlation of pancreatoblastoma: a case report. Pediatr Radiol 1993;23:61–62.
125. Montemarano H, Lonergan GJ, Bulas DI, et al. Pancreatoblastoma: imaging findings in 10 patients and review of the literature. Radiology 2000;214:476–482.
126. Roebuck DJ, Yuen MK, Wong YC, et al. Imaging features of pancreatoblastoma. Pediatr Radiol 2001;31:501–506.
127. Taxy JB. Adenocarcinoma of the pancreas in childhood. Report of a case and a review of the English language literature. Cancer 1976;37:1508–1518.
128. Moynan RW, Neerhout RC, Johnson TS. Pancreatic carcinoma in childhood: case report and review. J Pediatr 1964; 65:711–720.
129. Chiou YY, Chiang JH, Hwang JI, et al. Acinar cell carcinoma of the pancreas: clinical and computed tomography manifestations. J Comput Assist Tomogr 2004;28: 180–186.
130. Sun CD, Lee WJ, Choi JS, et al. Solid-pseudopapillary tumours of the pancreas: 14 years experience. ANZ J Surg 2005;75:684–689.
131. Tipton SG, Smyrk TC, Sarr MG, et al. Malignant potential of solid pseudopapillary neoplasm of the pancreas. Br J Surg 2006;93:733–737.
132. Wang KS, Albanese C, Dada F, et al. Papillary cystic neoplasm of the pancreas: a report of three pediatric cases and literature review. J Pediatr Surg 1998;33:842–845.
133. Zhou H, Cheng W, Lam KY, et al. Solid-cystic papillary tumor of the pancreas in children. Pediatr Surg Int 2001;17: 614–620.
134. Buetow PC, Buck JL, Pantongrag-Brown L, et al. Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation on 56 cases. Radiology 1996;199: 707–711.
135. Choi BI, Kim KW, Han MC, et al. Solid and papillary epithelial neoplasms of the pancreas: CT findings. Radiology 1988;166:413–416.
136. Kloppel G, Heitz PU. Pancreatic endocrine tumors. Pathol Res Pract 1988;183:155–168.
137. Van Nieuwenhove Y, Vandaele S, Op de Beeck B, et al. Neuroendocrine tumors of the pancreas. Surg Endosc 2003; 17:1658–1662.
138. Gouya H, Vignaux O, Augui J, et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol 2003;181: 987–992.
139. Sheth S, Hruban RK, Fishman EK. Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. AJR Am J Roentgenol 2002;179:725–730.
140. Buetow PC, Parrino TV, Buck JL, et al. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR Am J Roentgenol 1995;165: 1175–1179.
P.359

141. Buetow PC, Miller DL, Parrino TV, et al. Islet cell tumors of the pancreas: clinical, radiologic, and pathologic correlation in diagnosis and localization. Radiographics 1997;17: 453–472.
142. McClain MB, Burton EM, Day DS. Pancreatic pseudotumor in an 11-year-old child: imaging findings. Pediatr Radiol 2000;30:610–613.
143. Slavotinek JP, Bourne AJ, Sage MR, et al. Inflammatory pseudotumour of the pancreas in a child. Pediatr Radiol 2000;30:801–803.
144. Lin H, Li SD, Hu XG, et al. Primary pancreatic lymphoma: report of six cases. World J Gastroenterol 2006;12:5064– 5067.
145. Friedman AC, Edmonds PR. Rare pancreatic malignancies. Radiol Clin North Am 1989;27:177–190.
146. Pietsch JB, Shankar S, Ford C, et al. Obstructive jaundice secondary to lymphoma in childhood. J Pediatr Surg 2001;36:1792–1795.
147. Jacobs JE, Dinsmore BJ. Mature cystic teratoma of the pancreas: sonographic and CT findings. AJR Am J Roentgenol 1993;160:523–524.
148. Mester M, Trajber HJ, Compton CC, et al. Cystic teratomas of the pancreas. Arch Surg 1990;125:1215–1218.
149. Ros PR, Hamrick-Turner JE, Chiechi MV, et al. Cystic masses of the pancreas. Radiographics 1992;12:673–686.
150. Yu CW, Liu KL, Lin WC, et al. Mature cystic teratoma of the pancreas in a child. Pediatr Radiol 2003;33:266–268.
151. Movahedi-Lankarani S, Hruban RH, Westra WH, et al. Primitive neuroectodermal tumors of the pancreas: a report of seven cases of a rare neoplasm. Am J Surg Pathol 2002; 26:1040–1047.
152. Yasuda I, Adachi S, Kasahara S, et al. Pancreatic rhabdomyosarcoma. Gastrointest Endosc 2004;60:433–434.
153. Tunell WP. Hemangioendothelioma of the pancreas obstructing the common bile duct and duodenum. J Pediatr Surg 1976;11:827–830.
154. Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999;230:152–161.
155. Auringer ST, Ulmer JL, Sumner TE, et al. Congenital cyst of the pancreas. J Pediatr Surg 1993;28:1570–1571.
156. Kazez A, Akpolat N, Kocakoc E, et al. Congenital true pancreatic cyst: a rare case. Diagn Interv Radiol 2006;12:31–33.
157. Choyke PL, Glenn GM, Walther MM, et al. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995;194:629–642.
158. Delman KA, Shapiro SE, Jonasch EW, et al. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg 2006;30:665–669.
159. Dorfman RE, Alpern MB, Gross BH, et al. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991;180:319–322.
160. Einstein DM, Singer AA, Chilcote WA, et al. Abdominal lymphadenopathy: spectrum of CT findings. Radiographics 1991;11:457–472.
161. Hilton S, Herr HW, Teitcher JB, et al. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol 1997;169:521–525.
162. Warshauer DM, Lee KTL, Patel H. Retroperitoneum. In: Lee JKT, Sagel SS, Stanley RJ, et al., eds. Computed Body Tomography with MRI Correlation. Philadelphia: Lippincott Williams & Wilkins; 2006:1155–1233.
163. Pombo F, Rodriguez E, Mato J, et al. Patterns of contrast enhancement of tuberculous lymph nodes demonstrated by computed tomography. Clin Radiol 1992;46:13–17.
164. Radin DR. Intraabdominal Mycobacterium tuberculosis vs. Mycobacterium avium-intracellulare infections in patients with AIDS: distinction based on CT findings. AJR Am J Roentgenol 1991;156:487–491.
165. Hudson MM, Onciu M, Donaldson SS. Hodgkin lymphoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006:695–721.
166. Link MP, Weinstein HJ. Malignant non-Hodgkin lymphoma in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006:722–747.
167. Hueltenschmidt B, Sautter-Bihl ML, Lang O, et al. Whole body positron emission tomography in the treatment of Hodgkin disease. Cancer 2001;9:302–310.
168. Kazama T, Faria SC, Varavithya V, et al. FDG PET in the evaluation of treatment for lymphoma: clinical usefulness and pitfalls. Radiographics 2005:25:191–207.
169. Rhodes MM, Delbeke D, Whitlock JA, et al. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma. J Pediatr Hematol Oncol 2006;28: 300–306.
170. Cushing B, Perlman EJ, Marina NM, et al. Germ cell tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins; 2006:1116–1138.
171. Skoog SJ. Benign and malignant pediatric scrotal masses. Pediatr Clin North Am 1997;44:1229–1250.
172. Panicek DM, Toner GC, Heelan RT, et al. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy. Radiology 1990;175:499–502.
173. Stomper PC, Kalish LA, Garnick MB, et al. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology 1991;180:711–714.
174. Yang DM, Jung DH, Kim H, et al. Retroperitoneal cystic masses: CT, clinical and pathologic findings and literature review. Radiographics 2004;24:1353–1365.
175. Davidson AJ, Hartman DS, Goldman SM. Mature teratoma of the retroperitoneum: radiologic, pathologic, and clinical correlation. Radiology 1989;172:421–425.
176. Luo CC, Huang CS, Chu SM, et al. Retroperitoneal teratomas in infancy and childhood. Pediatr Surg Int 2005;21:536–540.
177. Davidson AJ, Hartman DS. Lymphangioma of the retroperitoneum: CT and sonographic characteristic. Radiology 1990;175:507–510.
178. Wilson SR, Bohrer S, Losada R, et al. Retroperitoneal lymphangioma: an unusual location and presentation. J Pediatr Surg 2006;41:603–605.
179. Mali VP, Tan HC, Loh D, et al. Inflammatory tumour of the retroperitoneum—a case report. Ann Acad Med Singapore 2005;34:632–635.
180. Bass JC, Korobkin M, Francis IR, et al. Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 1994;163:617–620.
181. Fenton LZ, Foreman N, Wyatt-Ashmead J. Diffuse, retroperitoneal mesenteric and intrahepatic periportal plexiform neurofibroma in a 5-year-old boy. Pediatr Radiol 2001;31:637–639.
182. Pui MH, Liu MJ, Guo Y, et al. Computed tomography of retroperitoneal paragangliomas. Australas Radiol 1999;43: 303–306.
183. Scherer A, Niehues T, Engelbrecht V, et al. Imaging diagnosis of retroperitoneal ganglioneuroma in childhood. Pediatr Radiol 2001;31:106–110.
184. Wong CH, Dietrich RB, Pais MJ, et al. Pediatric case of the day. Congenital, undifferentiated retroperitoneal fibrosarcoma. Radiographics 1994;14:1428–1430.
185. Jeffrey RB Jr, Cardoza JD, Olcott EW. Detection of active intraabdominal arterial hemorrhage: value of dynamic contrast-enhanced CT. AJR Am J Roentgenol 1991;156: 725–729.
186. Swenson SJ, McLeod RA, Stephens DH. CT of extracranial hemorrhage and hematomas. AJR Am J Roentgenol 1984; 143:907–912.
P.360

187. Amis ES Jr. Retroperitoneal fibrosis. AJR Am J Roentgenol 1991;157:321–329.
188. Miller OF, Smith LJ, Ferrara EX, et al. Presentation of idiopathic retroperitoneal fibrosis in the pediatric population. J Pediatr Surg 2003;38:1685–1688.
189. Sherman C, Winchester P, Brill PW, et al. Childhood retroperitoneal fibrosis. Pediatr Radiol 1988;18:245–247.
190. LeBlanc CM, Inman RD, Dent P, et al. Retroperitoneal fibrosis: an extraarticular manifestation of ankylosing spondylitis. Arthritis Rheum 2002;47:210–214.
191. Mulligan SA, Holley HC, Koehler RE, et al. CT and MR imaging in the evaluation of retroperitoneal fibrosis. J Comput Assist Tomogr 1989;13:277–281.
192. Muttarak M, Peh WC. CT of unusual iliopsoas compartment lesions. Radiographics 2000;20::S53–66.
193. Atkinson C, Morris SK, Ng V, et al. A child with fever, hip pain and limp. CMAJ 2006;174:924.
194. Lenchik L, Dovgan DJ, Kier R. CT of the iliopsoas compartment: value in differentiating tumor, abscess, and hematoma. AJR Am J Roentgenol 1994;162:83–86.